[
  {
    "problem_id": "1",
    "pred_problem_type": "Causal",
    "reason": [
      "causal verb",
      "intervention effect"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "Outcome Measurement: Percentage of Patients Achieving FEV1 Improvement \u226515% After 6 Weeks of Inhaled Budesonide. Spirometry was performed at baseline and at Week 6. Time frame: 6 weeks. Results: 54.8% (17/31) met the improvement threshold.",
    "statement": "Inhaled budesonide improves lung function in patients.",
    "description": "Solve causal reasoning problem. Statements making causal claims \u201ceffect of T on Y\u201d (e.g., cause, lead to, improve, reduce, accelerate;). May include or omit an interventional contrast or comparator to verify.",
    "label": "neutral",
    "gt_problem_type": "epsitemic",
    "selected_agents": [
      "causal_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_1, ques_1 -> causal_solver, causal_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The statement claims that inhaled budesonide improves lung function in patients. In the premise, the outcome measured is the percentage of patients achieving FEV1 improvement \u226515% after 6 weeks of using inhaled budesonide. The data indicate that 54.8% of patients (17/31) met this threshold. Improvement of \u226515% in FEV1 is a direct measure of improved lung function. However, the premise does not provide a comparison to a control or baseline group that did not receive inhaled budesonide to establish causality. Without this comparator, we cannot confirm that the improvement is specifically due to the inhaled budesonide, as no causal inference can definitively be drawn. Thus, the evidence remains insufficient to fully support the causal claim made in the statement.",
        "pred": "neutral",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "The statement claims that inhaled budesonide improves lung function in patients. In the premise, the outcome measured is the percentage of patients achieving FEV1 improvement \u226515% after 6 weeks of using inhaled budesonide. The data indicate that 54.8% of patients (17/31) met this threshold. Improvement of \u226515% in FEV1 is a direct measure of improved lung function. However, the premise does not provide a comparison to a control or baseline group that did not receive inhaled budesonide to establish causality. Without this comparator, we cannot confirm that the improvement is specifically due to the inhaled budesonide, as no causal inference can definitively be drawn. Thus, the evidence remains insufficient to fully support the causal claim made in the statement.",
      "pred": "neutral",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "2",
    "pred_problem_type": "Risk",
    "reason": [
      "risk to immune function",
      "risk to nerve health"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "Adverse Events Summary: Total: 6/14 (42.86%). Neutropenia 2/14 (14.29%), Peripheral neuropathy 1/14 (7.14%), Diarrhea 2/14 (14.29%), Hyponatremia 1/14 (7.14%).",
    "statement": "The treatment was effective but associated with risks to immune function and nerve health.",
    "description": "Solve risk reasoning problem. Risk ranking or comparison (highest risk, safer, dangerous), weighing severity against frequency, expected-harm reasoning, and hazards not ruled out by the premise.",
    "label": "neutral",
    "gt_problem_type": "epsitemic",
    "selected_agents": [
      "risk_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_2, ques_2 -> risk_solver, risk_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "From the premise, we note that adverse events occurred in 42.86% of patients receiving the treatment, with specific events listed: neutropenia (14.29%), peripheral neuropathy (7.14%), diarrhea (14.29%), and hyponatremia (7.14%). Neutropenia is directly indicative of risks to immune function due to the decrease in neutrophils, which are critical for fighting infections. Peripheral neuropathy points to risks to nerve health as it refers to damage or dysfunction of peripheral nerves, potentially causing debilitating symptoms. The statement asserts that the treatment was effective but associated with risks to immune function and nerve health. The premise does not address the effectiveness of the treatment, so that portion of the statement is outside the scope of the risk-focused reasoning in the premise. However, the risks to immune function and nerve health are clearly supported by the adverse events provided in the premise. Thus, the portion of the statement regarding risks is validated by the data.",
        "pred": "entailment",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "From the premise, we note that adverse events occurred in 42.86% of patients receiving the treatment, with specific events listed: neutropenia (14.29%), peripheral neuropathy (7.14%), diarrhea (14.29%), and hyponatremia (7.14%). Neutropenia is directly indicative of risks to immune function due to the decrease in neutrophils, which are critical for fighting infections. Peripheral neuropathy points to risks to nerve health as it refers to damage or dysfunction of peripheral nerves, potentially causing debilitating symptoms. The statement asserts that the treatment was effective but associated with risks to immune function and nerve health. The premise does not address the effectiveness of the treatment, so that portion of the statement is outside the scope of the risk-focused reasoning in the premise. However, the risks to immune function and nerve health are clearly supported by the adverse events provided in the premise. Thus, the portion of the statement regarding risks is validated by the data.",
      "pred": "entailment",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": false,
    "error_info": []
  },
  {
    "problem_id": "3",
    "pred_problem_type": "Causal",
    "reason": [
      "causal verb",
      "pre-post outcome"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "Outcome Measurement: Proportion of Patients With Resting Heart Rate <80 bpm at Week 12 After Ivabradine Therapy. Baseline average: 94 bpm. Results: 61.9% (26/42) achieved the target. Time frame: 12 weeks.",
    "statement": "Ivabradine lowers resting heart rate in patients.",
    "description": "Solve causal reasoning problem. Statements making causal claims \u201ceffect of T on Y\u201d (e.g., cause, lead to, improve, reduce, accelerate;). May include or omit an interventional contrast or comparator to verify.",
    "label": "neutral",
    "gt_problem_type": "epsitemic",
    "selected_agents": [
      "causal_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_3, ques_3 -> causal_solver, causal_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The treatment (T) in the premise is Ivabradine, and the outcome (Y) is a reduction in resting heart rate. The premise specifies that the proportion of patients achieving a resting heart rate <80 bpm after 12 weeks of Ivabradine therapy was 61.9%, starting from a baseline of 94 bpm. However, the premise only provides post-treatment data on how many patients achieved the target heart rate, without explicitly stating whether Ivabradine caused the reduction compared to a control group or baseline measurement over time. While the results suggest potential efficacy, without a direct comparison or control, causality cannot be definitively established. Thus, the evidence does not firmly support or contradict the causal claim in the statement.",
        "pred": "neutral",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "The treatment (T) in the premise is Ivabradine, and the outcome (Y) is a reduction in resting heart rate. The premise specifies that the proportion of patients achieving a resting heart rate <80 bpm after 12 weeks of Ivabradine therapy was 61.9%, starting from a baseline of 94 bpm. However, the premise only provides post-treatment data on how many patients achieved the target heart rate, without explicitly stating whether Ivabradine caused the reduction compared to a control group or baseline measurement over time. While the results suggest potential efficacy, without a direct comparison or control, causality cannot be definitively established. Thus, the evidence does not firmly support or contradict the causal claim in the statement.",
      "pred": "neutral",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "4",
    "pred_problem_type": "Causal",
    "reason": [
      "causal verb",
      "single-arm/no comparator"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "Outcome Measurement: Percentage of Participants With Fasting Plasma Glucose <100 mg/dL After 16 Weeks of Pioglitazone. Baseline and Week 16 measurements taken. Results: 47.6% (20/42) reached the target. Time frame: 16 weeks.",
    "statement": "Pioglitazone causes a reduction in fasting plasma glucose levels.",
    "description": "Solve causal reasoning problem. Statements making causal claims \u201ceffect of T on Y\u201d (e.g., cause, lead to, improve, reduce, accelerate;). May include or omit an interventional contrast or comparator to verify.",
    "label": "neutral",
    "gt_problem_type": "epsitemic",
    "selected_agents": [
      "causal_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_4, ques_4 -> causal_solver, causal_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The statement claims that Pioglitazone causes a reduction in fasting plasma glucose levels (T: Pioglitazone, Y: fasting plasma glucose levels). The premise provides data on the percentage of participants whose fasting plasma glucose levels were below 100 mg/dL after 16 weeks of taking Pioglitazone (47.6%). However, this evidence alone does not include a direct comparator, control group, or baseline data for fasting plasma glucose levels, making it unclear whether the reduction observed is caused by Pioglitazone or other factors. Without a comparison to a control group or baseline evidence indicating a reduction attributable to Pioglitazone, causality cannot be established. Therefore, the evidence is insufficient to support the causal claim.",
        "pred": "neutral",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "The statement claims that Pioglitazone causes a reduction in fasting plasma glucose levels (T: Pioglitazone, Y: fasting plasma glucose levels). The premise provides data on the percentage of participants whose fasting plasma glucose levels were below 100 mg/dL after 16 weeks of taking Pioglitazone (47.6%). However, this evidence alone does not include a direct comparator, control group, or baseline data for fasting plasma glucose levels, making it unclear whether the reduction observed is caused by Pioglitazone or other factors. Without a comparison to a control group or baseline evidence indicating a reduction attributable to Pioglitazone, causality cannot be established. Therefore, the evidence is insufficient to support the causal claim.",
      "pred": "neutral",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "5",
    "pred_problem_type": "Causal",
    "reason": [
      "causal verb",
      "adverse events listed"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "Adverse Events: Total: 8/22 (36.36%). Elevated creatinine 2/22 (9.09%), Ankle edema 3/22 (13.64%), Hypotension 2/22 (9.09%), Fatigue 1/22 (4.55%).",
    "statement": "The treatment was effective but some patients experienced kidney function changes, swelling, and low blood pressure.",
    "description": "Solve causal reasoning problem. Statements making causal claims \u201ceffect of T on Y\u201d (e.g., cause, lead to, improve, reduce, accelerate;). May include or omit an interventional contrast or comparator to verify.",
    "label": "neutral",
    "gt_problem_type": "epsitemic",
    "selected_agents": [
      "causal_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_5, ques_5 -> causal_solver, causal_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The premise provides information about adverse events observed during a treatment but lacks any mention of whether the treatment was effective. The adverse events listed include elevated creatinine, ankle edema, hypotension, and fatigue with their associated rates. Elevated creatinine can be understood as a change in kidney function, ankle edema as swelling, and hypotension as low blood pressure, which aligns with the adverse events described in the statement. However, since no causal evidence or comparison is provided about the effectiveness of the treatment, we cannot confirm or refute that part of the statement. The premise supports the second aspect (adverse events), but does not address the causal claim about treatment effectiveness.",
        "pred": "neutral",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "The premise provides information about adverse events observed during a treatment but lacks any mention of whether the treatment was effective. The adverse events listed include elevated creatinine, ankle edema, hypotension, and fatigue with their associated rates. Elevated creatinine can be understood as a change in kidney function, ankle edema as swelling, and hypotension as low blood pressure, which aligns with the adverse events described in the statement. However, since no causal evidence or comparison is provided about the effectiveness of the treatment, we cannot confirm or refute that part of the statement. The premise supports the second aspect (adverse events), but does not address the causal claim about treatment effectiveness.",
      "pred": "neutral",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "6",
    "pred_problem_type": "Risk",
    "reason": [
      "mild side effects",
      "risk superlative"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "Adverse Events Summary: Total: 4/12 (33.33%). Headache 2/12 (16.67%), Pruritus 1/12 (8.33%), Mild anemia 1/12 (8.33%). All events were Grade 1 or 2.",
    "statement": "The drug was effective and well tolerated, with only mild side effects reported.",
    "description": "Solve risk reasoning problem. Risk ranking or comparison (highest risk, safer, dangerous), weighing severity against frequency, expected-harm reasoning, and hazards not ruled out by the premise.",
    "label": "neutral",
    "gt_problem_type": "epsitemic",
    "selected_agents": [
      "risk_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_6, ques_6 -> risk_solver, risk_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The premise provides adverse event data where all side effects reported (headache, pruritus, mild anemia) are Grade 1 or 2, indicating mild or moderate severity. There are no Grade 3 or higher events (severe or life-threatening). The overall rate of adverse events is 33.33%, and specific adverse events are relatively infrequent (e.g., mild anemia 8.33%, pruritus 8.33%). The statement describes the drug as 'well tolerated' and states that side effects reported were only mild, which aligns with the adverse event data provided in the premise. The interpretation in the statement that the side effects are mild is consistent with the low severity of adverse events (Grade 1-2) described in the premise. Therefore, the statement is entailed by the premise.",
        "pred": "entailment",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "The premise provides adverse event data where all side effects reported (headache, pruritus, mild anemia) are Grade 1 or 2, indicating mild or moderate severity. There are no Grade 3 or higher events (severe or life-threatening). The overall rate of adverse events is 33.33%, and specific adverse events are relatively infrequent (e.g., mild anemia 8.33%, pruritus 8.33%). The statement describes the drug as 'well tolerated' and states that side effects reported were only mild, which aligns with the adverse event data provided in the premise. The interpretation in the statement that the side effects are mild is consistent with the low severity of adverse events (Grade 1-2) described in the premise. Therefore, the statement is entailed by the premise.",
      "pred": "entailment",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": false,
    "error_info": []
  },
  {
    "problem_id": "7",
    "pred_problem_type": "Causal",
    "reason": [
      "causal verb",
      "treatment \u2192 outcomes"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "Treatment-Emergent Adverse Events: 5/16 (31.25%). Hyperkalemia 1/16 (6.25%), Dizziness 2/16 (12.50%), Palpitations 1/16 (6.25%), Constipation 1/16 (6.25%).",
    "statement": "The treatment improved outcomes but some patients experienced electrolyte imbalances and cardiovascular symptoms.",
    "description": "Solve causal reasoning problem. Statements making causal claims \u201ceffect of T on Y\u201d (e.g., cause, lead to, improve, reduce, accelerate;). May include or omit an interventional contrast or comparator to verify.",
    "label": "neutral",
    "gt_problem_type": "epsitemic",
    "selected_agents": [
      "causal_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_7, ques_7 -> causal_solver, causal_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The premise provides data on treatment-emergent adverse events, listing specific side effects such as hyperkalemia (6.25%), dizziness (12.50%), palpitations (6.25%), and constipation (6.25%) in a treated group of 16 patients. The statement asserts that the treatment improved outcomes while also noting that some patients experienced electrolyte imbalances (hyperkalemia) and cardiovascular symptoms (palpitations). However, the premise does not provide any evidence supporting or refuting improvement in outcomes because it only reports adverse events without comparison to a control group or any baseline metrics. Thus, the premise does not confirm whether the treatment resulted in improved outcomes as claimed in the statement. The portion of the statement regarding electrolyte imbalances and cardiovascular symptoms aligns with the reported adverse events, but no causal evidence is provided for the positive improvement in outcomes. The lack of data regarding improvement renders this claim unsupported.",
        "pred": "neutral",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "The premise provides data on treatment-emergent adverse events, listing specific side effects such as hyperkalemia (6.25%), dizziness (12.50%), palpitations (6.25%), and constipation (6.25%) in a treated group of 16 patients. The statement asserts that the treatment improved outcomes while also noting that some patients experienced electrolyte imbalances (hyperkalemia) and cardiovascular symptoms (palpitations). However, the premise does not provide any evidence supporting or refuting improvement in outcomes because it only reports adverse events without comparison to a control group or any baseline metrics. Thus, the premise does not confirm whether the treatment resulted in improved outcomes as claimed in the statement. The portion of the statement regarding electrolyte imbalances and cardiovascular symptoms aligns with the reported adverse events, but no causal evidence is provided for the positive improvement in outcomes. The lack of data regarding improvement renders this claim unsupported.",
      "pred": "neutral",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "8",
    "pred_problem_type": "Causal",
    "reason": [
      "causal verb",
      "intervention\u2013outcome claim"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "Outcome: Percentage of patients achieving serum uric acid <6 mg/dL after 10 weeks of allopurinol. Results: 69.2% (18/26) achieved the target. Time frame: 10 weeks.",
    "statement": "Allopurinol effectively lowers serum uric acid in most patients.",
    "description": "Solve causal reasoning problem. Statements making causal claims \u201ceffect of T on Y\u201d (e.g., cause, lead to, improve, reduce, accelerate;). May include or omit an interventional contrast or comparator to verify.",
    "label": "neutral",
    "gt_problem_type": "epsitemic",
    "selected_agents": [
      "causal_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_8, ques_8 -> causal_solver, causal_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The intervention (T) in the premise is allopurinol, and the outcome (Y) is the percentage of patients achieving serum uric acid levels <6 mg/dL. The results indicate that 69.2% (18/26) of patients achieved the target after 10 weeks. The statement asserts that 'allopurinol effectively lowers serum uric acid in most patients,' which aligns with the data, as 69.2% constitutes a majority. Although the premise does not provide a comparison to a control or baseline, the observed proportion achieving the desired outcome post-intervention supports the claim that allopurinol was effective. Therefore, the evidence supports the causal direction implied in the statement.",
        "pred": "entailment",
        "fact_verification": "correct",
        "reasoning_verification": "incorrect",
        "overall_verification": false
      },
      {
        "reasoning": "The intervention (T) in the premise is allopurinol, and the outcome (Y) is the percentage of patients achieving serum uric acid levels below 6 mg/dL. The data in the premise shows that 69.2% (18/26) of patients achieved this target after 10 weeks of treatment with allopurinol. However, to establish causation, we require evidence comparing this result to a control group, an alternate intervention group, or a baseline measurement prior to treatment. The premise does not provide any such comparative information. While the 69.2% outcome suggests a potential association between allopurinol treatment and achieving the target uric acid level, it does not confirm causality as the statement implies. Without a comparator or temporal evidence explicitly linking the use of allopurinol to an improvement over another condition, we must characterize the relationship as correlational rather than causal. Thus, the evidence only partially supports the claim stated, making the appropriate label 'neutral.'",
        "pred": "neutral"
      }
    ],
    "solution_final": {
      "reasoning": "The intervention (T) in the premise is allopurinol, and the outcome (Y) is the percentage of patients achieving serum uric acid levels below 6 mg/dL. The data in the premise shows that 69.2% (18/26) of patients achieved this target after 10 weeks of treatment with allopurinol. However, to establish causation, we require evidence comparing this result to a control group, an alternate intervention group, or a baseline measurement prior to treatment. The premise does not provide any such comparative information. While the 69.2% outcome suggests a potential association between allopurinol treatment and achieving the target uric acid level, it does not confirm causality as the statement implies. Without a comparator or temporal evidence explicitly linking the use of allopurinol to an improvement over another condition, we must characterize the relationship as correlational rather than causal. Thus, the evidence only partially supports the claim stated, making the appropriate label 'neutral.'",
      "pred": "neutral"
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "9",
    "pred_problem_type": "Causal",
    "reason": [
      "causal verb",
      "intervention \u2192 outcome"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "Outcome: Rate of complete lesion clearance at Week 4 following topical 5-fluorouracil application for actinic keratosis. 55% (11/20) achieved complete clearance. Time frame: 4 weeks.",
    "statement": "Topical 5-fluorouracil accelerates lesion clearance in actinic keratosis.",
    "description": "Solve causal reasoning problem. Statements making causal claims \u201ceffect of T on Y\u201d (e.g., cause, lead to, improve, reduce, accelerate;). May include or omit an interventional contrast or comparator to verify.",
    "label": "neutral",
    "gt_problem_type": "epsitemic",
    "selected_agents": [
      "causal_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_9, ques_9 -> causal_solver, causal_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The treatment (T) in this case is topical 5-fluorouracil, and the outcome (Y) is lesion clearance in actinic keratosis. The premise provides the rate of complete lesion clearance (55%) after a 4-week application of the treatment, but it does not include a control or baseline group to compare whether this treatment accelerates lesion clearance relative to no treatment, another treatment, or typical lesion progression over time. Without comparative data or temporal acceleration evidence, the causal claim of acceleration cannot be fully assessed. The premise lacks sufficient evidence to establish the directionality or magnitude of the effect explicitly relative to a control or baseline.",
        "pred": "neutral",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "The treatment (T) in this case is topical 5-fluorouracil, and the outcome (Y) is lesion clearance in actinic keratosis. The premise provides the rate of complete lesion clearance (55%) after a 4-week application of the treatment, but it does not include a control or baseline group to compare whether this treatment accelerates lesion clearance relative to no treatment, another treatment, or typical lesion progression over time. Without comparative data or temporal acceleration evidence, the causal claim of acceleration cannot be fully assessed. The premise lacks sufficient evidence to establish the directionality or magnitude of the effect explicitly relative to a control or baseline.",
      "pred": "neutral",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "10",
    "pred_problem_type": "Causal",
    "reason": [
      "causal verb",
      "single-arm/no comparator"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "Outcome: Percentage of participants with \u226550% reduction in weekly migraine days at Week 8 following galcanezumab injections. 62.5% (15/24) met the reduction threshold. No control group included.",
    "statement": "Galcanezumab reduces migraine frequency significantly by Week 8.",
    "description": "Solve causal reasoning problem. Statements making causal claims \u201ceffect of T on Y\u201d (e.g., cause, lead to, improve, reduce, accelerate;). May include or omit an interventional contrast or comparator to verify.",
    "label": "neutral",
    "gt_problem_type": "epsitemic",
    "selected_agents": [
      "causal_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_10, ques_10 -> causal_solver, causal_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The statement claims that galcanezumab reduces migraine frequency significantly by Week 8. In the premise, 62.5% of participants showed a \u226550% reduction in weekly migraine days following galcanezumab injections by Week 8. However, the premise does not include a control group or baseline for comparison, which is essential to establish causality. Without a comparator or evidence showing that this reduction is attributable specifically to galcanezumab rather than other factors such as natural variation, placebo effect, or external interventions, the causal claim cannot be fully supported. Thus, the evidence is insufficient to confirm or refute the causal claim in the statement.",
        "pred": "neutral",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "The statement claims that galcanezumab reduces migraine frequency significantly by Week 8. In the premise, 62.5% of participants showed a \u226550% reduction in weekly migraine days following galcanezumab injections by Week 8. However, the premise does not include a control group or baseline for comparison, which is essential to establish causality. Without a comparator or evidence showing that this reduction is attributable specifically to galcanezumab rather than other factors such as natural variation, placebo effect, or external interventions, the causal claim cannot be fully supported. Thus, the evidence is insufficient to confirm or refute the causal claim in the statement.",
      "pred": "neutral",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "11",
    "pred_problem_type": "Epist",
    "reason": [
      "conflicting diagnosis",
      "objective imaging vs opinion"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "A 72-year-old man presents with sudden onset of right-sided weakness and slurred speech. CT scan shows an acute left middle cerebral artery territory infarct. The attending physician attributes the symptoms to low blood sugar and starts glucose infusion.",
    "statement": "The patient has an ischemic stroke.",
    "description": "Solve epistemic reasoning problem. Determining what is true from mixed or conflicting evidence within the premise. Includes resolution of contradictions between sources, preferring objective measurements (labs, imaging) over opinions, and establishing diagnostic status from an evidence hierarchy.",
    "label": "entailment",
    "gt_problem_type": "epsitemic",
    "selected_agents": [
      "epistemic_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_11, ques_11 -> epistemic_solver, epistemic_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The premise includes objective evidence from a CT scan indicating an acute left middle cerebral artery territory infarct, which is consistent with an ischemic stroke. The attending physician attributes the symptoms to low blood sugar and initiates a glucose infusion, which reflects their opinion but does not negate the objective CT findings. Objective imaging data hold higher weight in the evidence hierarchy than physician interpretation when they conflict. Therefore, the statement that the patient has an ischemic stroke is supported by the CT findings.",
        "pred": "entailment",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "The premise includes objective evidence from a CT scan indicating an acute left middle cerebral artery territory infarct, which is consistent with an ischemic stroke. The attending physician attributes the symptoms to low blood sugar and initiates a glucose infusion, which reflects their opinion but does not negate the objective CT findings. Objective imaging data hold higher weight in the evidence hierarchy than physician interpretation when they conflict. Therefore, the statement that the patient has an ischemic stroke is supported by the CT findings.",
      "pred": "entailment",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "12",
    "pred_problem_type": "Epist",
    "reason": [
      "conflicting diagnosis",
      "objective lab vs opinion"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "A 48-year-old woman reports progressive shortness of breath and swelling in her legs over several weeks. Echocardiogram reveals severely reduced left ventricular ejection fraction. The cardiologist diagnoses asthma and prescribes inhalers.",
    "statement": "The patient has heart failure.",
    "description": "Solve epistemic reasoning problem. Determining what is true from mixed or conflicting evidence within the premise. Includes resolution of contradictions between sources, preferring objective measurements (labs, imaging) over opinions, and establishing diagnostic status from an evidence hierarchy.",
    "label": "entailment",
    "gt_problem_type": "epsitemic",
    "selected_agents": [
      "epistemic_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_12, ques_12 -> epistemic_solver, epistemic_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The patient's report of progressive shortness of breath and leg swelling, coupled with echocardiogram findings of severely reduced left ventricular ejection fraction (LVEF), aligns with diagnostic criteria for heart failure (formal objective evidence at the top of the hierarchy). The cardiologist's diagnosis of asthma and prescription of inhalers is inconsistent with the echocardiogram findings, as reduced LVEF is not characteristic of asthma. Since echocardiographic results are more objective and carry greater evidentiary weight than a clinician's potentially erroneous interpretation, the evidence supports that the patient has heart failure.",
        "pred": "entailment",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "The patient's report of progressive shortness of breath and leg swelling, coupled with echocardiogram findings of severely reduced left ventricular ejection fraction (LVEF), aligns with diagnostic criteria for heart failure (formal objective evidence at the top of the hierarchy). The cardiologist's diagnosis of asthma and prescription of inhalers is inconsistent with the echocardiogram findings, as reduced LVEF is not characteristic of asthma. Since echocardiographic results are more objective and carry greater evidentiary weight than a clinician's potentially erroneous interpretation, the evidence supports that the patient has heart failure.",
      "pred": "entailment",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "13",
    "pred_problem_type": "Epist",
    "reason": [
      "conflicting diagnosis",
      "objective CSF vs opinion"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "A 30-year-old man presents with high fever, severe headache, neck stiffness, and photophobia. Lumbar puncture reveals cloudy cerebrospinal fluid with elevated white cell count and low glucose. The physician attributes symptoms to tension headache and prescribes analgesics.",
    "statement": "The patient has bacterial meningitis.",
    "description": "Solve epistemic reasoning problem. Determining what is true from mixed or conflicting evidence within the premise. Includes resolution of contradictions between sources, preferring objective measurements (labs, imaging) over opinions, and establishing diagnostic status from an evidence hierarchy.",
    "label": "entailment",
    "gt_problem_type": "epsitemic",
    "selected_agents": [
      "epistemic_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_13, ques_13 -> epistemic_solver, epistemic_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The premise describes a 30-year-old man with symptoms of high fever, severe headache, neck stiffness, and photophobia. These clinical features strongly suggest meningitis. The lumbar puncture findings further support this, revealing cloudy cerebrospinal fluid, elevated white cell count, and low glucose\u2014hallmark findings consistent with bacterial meningitis. While the physician attributes the symptoms to tension headache, this is a clinician's opinion that directly contradicts stronger objective evidence (lumbar puncture results). Based on the evidence hierarchy, the diagnostic criteria for bacterial meningitis are met by combining symptoms, cerebrospinal fluid analysis, and the exclusion of plausible alternative explanations (tension headache does not cause elevated white cells and low glucose in cerebrospinal fluid). The statement that the patient has bacterial meningitis is therefore entailed.",
        "pred": "entailment",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "The premise describes a 30-year-old man with symptoms of high fever, severe headache, neck stiffness, and photophobia. These clinical features strongly suggest meningitis. The lumbar puncture findings further support this, revealing cloudy cerebrospinal fluid, elevated white cell count, and low glucose\u2014hallmark findings consistent with bacterial meningitis. While the physician attributes the symptoms to tension headache, this is a clinician's opinion that directly contradicts stronger objective evidence (lumbar puncture results). Based on the evidence hierarchy, the diagnostic criteria for bacterial meningitis are met by combining symptoms, cerebrospinal fluid analysis, and the exclusion of plausible alternative explanations (tension headache does not cause elevated white cells and low glucose in cerebrospinal fluid). The statement that the patient has bacterial meningitis is therefore entailed.",
      "pred": "entailment",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "14",
    "pred_problem_type": "Epist",
    "reason": [
      "conflicting diagnosis",
      "objective lab vs opinion"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "A 62-year-old woman experiences sudden loss of vision in one eye. Fundoscopic examination reveals a pale retina with a cherry-red spot at the macula. The ophthalmologist suspects conjunctivitis and prescribes antibiotic drops.",
    "statement": "The patient has central retinal artery occlusion.",
    "description": "Solve epistemic reasoning problem. Determining what is true from mixed or conflicting evidence within the premise. Includes resolution of contradictions between sources, preferring objective measurements (labs, imaging) over opinions, and establishing diagnostic status from an evidence hierarchy.",
    "label": "entailment",
    "gt_problem_type": "epsitemic",
    "selected_agents": [
      "epistemic_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_14, ques_14 -> epistemic_solver, epistemic_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The premise includes specific findings: a sudden loss of vision in one eye, a pale retina, and a cherry-red spot at the macula observed during a fundoscopic examination. These findings are consistent with the hallmark presentation of central retinal artery occlusion (CRAO) and align with formal diagnostic criteria for CRAO. The ophthalmologist\u2019s suspicion of conjunctivitis and prescription of antibiotic drops directly contradicts the objective fundoscopic findings and does not align with the clinical picture of CRAO. Based on the evidence hierarchy, the objectively observed findings from the fundoscopic exam outweigh the clinician's incorrect interpretation. Therefore, the statement that the patient has central retinal artery occlusion is entailed.",
        "pred": "entailment",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "The premise includes specific findings: a sudden loss of vision in one eye, a pale retina, and a cherry-red spot at the macula observed during a fundoscopic examination. These findings are consistent with the hallmark presentation of central retinal artery occlusion (CRAO) and align with formal diagnostic criteria for CRAO. The ophthalmologist\u2019s suspicion of conjunctivitis and prescription of antibiotic drops directly contradicts the objective fundoscopic findings and does not align with the clinical picture of CRAO. Based on the evidence hierarchy, the objectively observed findings from the fundoscopic exam outweigh the clinician's incorrect interpretation. Therefore, the statement that the patient has central retinal artery occlusion is entailed.",
      "pred": "entailment",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "15",
    "pred_problem_type": "Epist",
    "reason": [
      "conflicting diagnosis",
      "objective lab+imaging"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "A 54-year-old male presents with severe epigastric pain radiating to the back, elevated serum lipase, and abdominal CT confirming pancreatic inflammation. The clinician diagnoses gastritis and starts proton pump inhibitors.",
    "statement": "The patient has acute pancreatitis.",
    "description": "Solve epistemic reasoning problem. Determining what is true from mixed or conflicting evidence within the premise. Includes resolution of contradictions between sources, preferring objective measurements (labs, imaging) over opinions, and establishing diagnostic status from an evidence hierarchy.",
    "label": "entailment",
    "gt_problem_type": "epsitemic",
    "selected_agents": [
      "epistemic_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_15, ques_15 -> epistemic_solver, epistemic_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The premise includes objective evidence such as 'elevated serum lipase' and an 'abdominal CT confirming pancreatic inflammation,' both of which are consistent with acute pancreatitis according to formal diagnostic criteria. These findings outweigh the clinician's diagnosis of gastritis, which lacks supporting evidence in the premise. Therefore, the presented evidence strongly supports the statement that the patient has acute pancreatitis.",
        "pred": "entailment",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "The premise includes objective evidence such as 'elevated serum lipase' and an 'abdominal CT confirming pancreatic inflammation,' both of which are consistent with acute pancreatitis according to formal diagnostic criteria. These findings outweigh the clinician's diagnosis of gastritis, which lacks supporting evidence in the premise. Therefore, the presented evidence strongly supports the statement that the patient has acute pancreatitis.",
      "pred": "entailment",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "16",
    "pred_problem_type": "Epist",
    "reason": [
      "conflicting assertions",
      "objective lab vs opinion"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "A 45-year-old man complains of chest discomfort after meals and occasional regurgitation. Endoscopy is normal. Despite the absence of cardiac symptoms, the physician diagnoses myocardial infarction and starts anticoagulation therapy.",
    "statement": "The patient has myocardial infarction.",
    "description": "Solve epistemic reasoning problem. Determining what is true from mixed or conflicting evidence within the premise. Includes resolution of contradictions between sources, preferring objective measurements (labs, imaging) over opinions, and establishing diagnostic status from an evidence hierarchy.",
    "label": "contradiction",
    "gt_problem_type": "epsitemic",
    "selected_agents": [
      "epistemic_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_16, ques_16 -> epistemic_solver, epistemic_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The premise contains conflicting evidence regarding the diagnosis of myocardial infarction. On one hand, the physician has diagnosed myocardial infarction and initiated anticoagulation therapy, which is a clinician's opinion or interpretation. On the other hand, the symptoms described\u2014chest discomfort after meals and regurgitation\u2014are more consistent with gastroesophageal reflux disease (GERD) rather than cardiac issues, and no objective cardiac diagnostic tests or formal criteria (e.g., ECG, cardiac enzymes, imaging findings) are reported to confirm myocardial infarction. Since no objective evidence supports the physician's diagnosis, and the described symptoms do not strongly align with myocardial infarction, the evidence hierarchy prioritizes the lack of supporting objective evidence. This makes the diagnosis of myocardial infarction unsupported. Thus, the statement that 'The patient has myocardial infarction' is contradicted.",
        "pred": "contradiction",
        "fact_verification": "fact_verification_error",
        "reasoning_verification": "reasoning_verification_error",
        "overall_verification": false
      },
      {
        "reasoning": "The premise provides information about a 45-year-old man experiencing chest discomfort after meals and occasional regurgitation. These symptoms are not specific to myocardial infarction and align more with gastroesophageal reflux disease (GERD). The premise also mentions that endoscopy is normal, which likely rules out other esophageal conditions but does not provide evidence for a cardiac issue. Despite this, the physician diagnoses myocardial infarction and initiates anticoagulation therapy, a significant clinical decision. However, the premise lacks any objective cardiac diagnostic evidence (such as ECG, cardiac enzyme levels, or imaging results) to confirm this diagnosis. According to the evidence hierarchy, objective recorded data holds more weight than clinician opinion in the absence of corroborative signs or tests. The absence of such evidence combined with the non-specific symptomatology for myocardial infarction makes it highly improbable to confirm this diagnosis. Thus, the statement 'The patient has myocardial infarction' is contradicted.",
        "pred": "contradiction"
      }
    ],
    "solution_final": {
      "reasoning": "The premise provides information about a 45-year-old man experiencing chest discomfort after meals and occasional regurgitation. These symptoms are not specific to myocardial infarction and align more with gastroesophageal reflux disease (GERD). The premise also mentions that endoscopy is normal, which likely rules out other esophageal conditions but does not provide evidence for a cardiac issue. Despite this, the physician diagnoses myocardial infarction and initiates anticoagulation therapy, a significant clinical decision. However, the premise lacks any objective cardiac diagnostic evidence (such as ECG, cardiac enzyme levels, or imaging results) to confirm this diagnosis. According to the evidence hierarchy, objective recorded data holds more weight than clinician opinion in the absence of corroborative signs or tests. The absence of such evidence combined with the non-specific symptomatology for myocardial infarction makes it highly improbable to confirm this diagnosis. Thus, the statement 'The patient has myocardial infarction' is contradicted.",
      "pred": "contradiction"
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "17",
    "pred_problem_type": "Epist",
    "reason": [
      "diagnostic claim",
      "labs vs opinion"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "A 28-year-old woman presents with diffuse abdominal pain, bloating, and irregular bowel movements for several months. Colonoscopy is unremarkable. The physician diagnoses colon cancer and refers her for chemotherapy.",
    "statement": "The patient has colon cancer.",
    "description": "Solve epistemic reasoning problem. Determining what is true from mixed or conflicting evidence within the premise. Includes resolution of contradictions between sources, preferring objective measurements (labs, imaging) over opinions, and establishing diagnostic status from an evidence hierarchy.",
    "label": "contradiction",
    "gt_problem_type": "epsitemic",
    "selected_agents": [
      "epistemic_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_17, ques_17 -> epistemic_solver, epistemic_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The premise includes conflicting information. On one hand, the premise mentions that colonoscopy\u2014a key diagnostic tool for colon cancer\u2014is unremarkable, suggesting no evidence of colon cancer. On the other hand, the physician diagnoses colon cancer and refers the patient for chemotherapy. Since the colonoscopy result is an objective diagnostic finding (instrumented evidence) and ranks higher on the evidence hierarchy than a clinician's interpretation (which, in this case, appears unsupported by objective data), the claim of colon cancer is not substantiated. The higher weight given to the unremarkable colonoscopy contradicts the physician's diagnosis of colon cancer. Thus, the patient does not have confirmed colon cancer based on this premise.",
        "pred": "contradiction",
        "fact_verification": "fact_verification_error",
        "reasoning_verification": "reasoning_verification_error",
        "overall_verification": false
      },
      {
        "reasoning": "The premise describes a 28-year-old woman experiencing abdominal symptoms for several months, but her colonoscopy, a key diagnostic tool for detecting colon cancer, is unremarkable. Although the physician diagnoses colon cancer and refers the patient for chemotherapy, the unremarkable colonoscopy result takes precedence as it represents higher-ranked evidence on the evidence hierarchy (instrumented data over clinician interpretation). This creates a conflict between the objective diagnostic procedure and the physician's assertion. Since the objective evidence does not support the diagnosis of colon cancer, the claim that the patient has colon cancer is contradicted by the premise.",
        "pred": "contradiction"
      }
    ],
    "solution_final": {
      "reasoning": "The premise describes a 28-year-old woman experiencing abdominal symptoms for several months, but her colonoscopy, a key diagnostic tool for detecting colon cancer, is unremarkable. Although the physician diagnoses colon cancer and refers the patient for chemotherapy, the unremarkable colonoscopy result takes precedence as it represents higher-ranked evidence on the evidence hierarchy (instrumented data over clinician interpretation). This creates a conflict between the objective diagnostic procedure and the physician's assertion. Since the objective evidence does not support the diagnosis of colon cancer, the claim that the patient has colon cancer is contradicted by the premise.",
      "pred": "contradiction"
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "18",
    "pred_problem_type": "Epist",
    "reason": [
      "diagnostic status",
      "objective labs vs opinion"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "A 61-year-old woman arrives with gradual onset of numbness and tingling in her feet. Nerve conduction studies are normal. The neurologist diagnoses Guillain\u2013Barr\u00e9 syndrome and admits her for IVIG therapy.",
    "statement": "The patient has Guillain\u2013Barr\u00e9 syndrome.",
    "description": "Solve epistemic reasoning problem. Determining what is true from mixed or conflicting evidence within the premise. Includes resolution of contradictions between sources, preferring objective measurements (labs, imaging) over opinions, and establishing diagnostic status from an evidence hierarchy.",
    "label": "contradiction",
    "gt_problem_type": "epsitemic",
    "selected_agents": [
      "epistemic_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_18, ques_18 -> epistemic_solver, epistemic_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "Parsing the premise reveals the following claims: (1) The patient is a 61-year-old woman with gradual onset of numbness and tingling in her feet. (2) Nerve conduction studies are normal. (3) The neurologist diagnoses Guillain\u2013Barr\u00e9 syndrome and admits her for IVIG therapy. Guillain\u2013Barr\u00e9 syndrome (GBS) is typically characterized by progressive, symmetrical weakness and areflexia, and diagnostic confirmation often includes abnormal nerve conduction studies showing demyelination or axonal injury. However, in this case, the nerve conduction studies are stated to be normal, which is inconsistent with common expected findings for GBS. The neurologist's diagnosis is based on their clinical judgment, but this is insufficiently supported by the objective test results presented. Applying the evidence hierarchy, the normal nerve conduction studies take precedence over the neurologist's diagnosis. Therefore, whether the patient has GBS cannot be definitively established from the premise.",
        "pred": "neutral",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "Parsing the premise reveals the following claims: (1) The patient is a 61-year-old woman with gradual onset of numbness and tingling in her feet. (2) Nerve conduction studies are normal. (3) The neurologist diagnoses Guillain\u2013Barr\u00e9 syndrome and admits her for IVIG therapy. Guillain\u2013Barr\u00e9 syndrome (GBS) is typically characterized by progressive, symmetrical weakness and areflexia, and diagnostic confirmation often includes abnormal nerve conduction studies showing demyelination or axonal injury. However, in this case, the nerve conduction studies are stated to be normal, which is inconsistent with common expected findings for GBS. The neurologist's diagnosis is based on their clinical judgment, but this is insufficiently supported by the objective test results presented. Applying the evidence hierarchy, the normal nerve conduction studies take precedence over the neurologist's diagnosis. Therefore, whether the patient has GBS cannot be definitively established from the premise.",
      "pred": "neutral",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": false,
    "error_info": []
  },
  {
    "problem_id": "19",
    "pred_problem_type": "Epist",
    "reason": [
      "conflicting evidence",
      "labs vs diagnosis"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "A 39-year-old man reports intense thirst, frequent urination, and unexplained weight loss. Fasting blood glucose is 98 mg/dL, and HbA1c is within normal range. The physician diagnoses type 1 diabetes mellitus.",
    "statement": "The patient has type 1 diabetes mellitus.",
    "description": "Solve epistemic reasoning problem. Determining what is true from mixed or conflicting evidence within the premise. Includes resolution of contradictions between sources, preferring objective measurements (labs, imaging) over opinions, and establishing diagnostic status from an evidence hierarchy.",
    "label": "contradiction",
    "gt_problem_type": "epsitemic",
    "selected_agents": [
      "epistemic_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_19, ques_19 -> epistemic_solver, epistemic_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The premise describes a 39-year-old man with symptoms of intense thirst, frequent urination, and unexplained weight loss, which could be suggestive of diabetes. However, the objective laboratory results provided (fasting blood glucose of 98 mg/dL and HbA1c within normal range) do not support a diagnosis of diabetes mellitus, as these values are within healthy ranges. While the physician has stated a diagnosis of type 1 diabetes mellitus, this claim conflicts with the stronger objective evidence from the lab results. According to the evidence hierarchy, the lab results carry greater weight than the clinician's opinion, making the claim of type 1 diabetes unsupported by the available data.",
        "pred": "contradiction",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "The premise describes a 39-year-old man with symptoms of intense thirst, frequent urination, and unexplained weight loss, which could be suggestive of diabetes. However, the objective laboratory results provided (fasting blood glucose of 98 mg/dL and HbA1c within normal range) do not support a diagnosis of diabetes mellitus, as these values are within healthy ranges. While the physician has stated a diagnosis of type 1 diabetes mellitus, this claim conflicts with the stronger objective evidence from the lab results. According to the evidence hierarchy, the lab results carry greater weight than the clinician's opinion, making the claim of type 1 diabetes unsupported by the available data.",
      "pred": "contradiction",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "20",
    "pred_problem_type": "Epist",
    "reason": [
      "conflicting evidence",
      "objective imaging vs opinion"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "A 56-year-old man presents with persistent cough and hemoptysis. Chest CT is clear, with no evidence of masses or infiltrates. The physician diagnoses lung cancer and begins chemotherapy.",
    "statement": "The patient has lung cancer.",
    "description": "Solve epistemic reasoning problem. Determining what is true from mixed or conflicting evidence within the premise. Includes resolution of contradictions between sources, preferring objective measurements (labs, imaging) over opinions, and establishing diagnostic status from an evidence hierarchy.",
    "label": "contradiction",
    "gt_problem_type": "epsitemic",
    "selected_agents": [
      "epistemic_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_20, ques_20 -> epistemic_solver, epistemic_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "Parsing the premise, we find the following relevant claims: 1) The patient, a 56-year-old man, presents with persistent cough and hemoptysis. 2) A chest CT shows no evidence of masses or infiltrates. 3) The physician diagnoses lung cancer and begins chemotherapy. Evaluating these claims, the chest CT - an objective imaging modality - shows no evidence of masses or infiltrates, which contradicts the diagnosis of lung cancer, as the latter typically requires confirmation via findings such as imaging abnormalities, biopsy, or other supporting criteria. The physician's diagnosis, while authoritative, carries less weight than the absence of corroborating objective evidence from the CT scan. As the claim of lung cancer is inconsistent with the strongest evidence presented, we reject it. Therefore, the statement that the patient has lung cancer is contradicted.",
        "pred": "contradiction",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "Parsing the premise, we find the following relevant claims: 1) The patient, a 56-year-old man, presents with persistent cough and hemoptysis. 2) A chest CT shows no evidence of masses or infiltrates. 3) The physician diagnoses lung cancer and begins chemotherapy. Evaluating these claims, the chest CT - an objective imaging modality - shows no evidence of masses or infiltrates, which contradicts the diagnosis of lung cancer, as the latter typically requires confirmation via findings such as imaging abnormalities, biopsy, or other supporting criteria. The physician's diagnosis, while authoritative, carries less weight than the absence of corroborating objective evidence from the CT scan. As the claim of lung cancer is inconsistent with the strongest evidence presented, we reject it. Therefore, the statement that the patient has lung cancer is contradicted.",
      "pred": "contradiction",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "21",
    "pred_problem_type": "Comp",
    "reason": [
      "causal verb",
      "dose+diagnosis+schedule"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "70-year-old male with chronic lymphocytic leukemia receiving fludarabine 120mg/m\u00b2 intravenously daily for 14 consecutive days per cycle.",
    "statement": "The treatment is expected to induce remission, improve blood counts, and prolong survival.",
    "description": "Solve compositional reasoning problem. Joint constraints over drug\u2013dose\u2013units\u2013schedule\u2013diagnosis\u2013patient factors (age, sex, renal/hepatic function, comorbidities) and co-therapy. Includes dosing bounds, indications, exclusions, and concurrency rules.",
    "label": "contradiction",
    "gt_problem_type": "risk",
    "selected_agents": [
      "compositional_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_21, ques_21 -> compositional_solver, compositional_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "To evaluate the statement, we must consider the noted treatment (fludarabine 120mg/m\u00b2 intravenously daily for 14 days per cycle), the patient profile (70-year-old male with chronic lymphocytic leukemia, or CLL), and the expected outcomes (induction of remission, improvement in blood counts, and prolonged survival). Fludarabine is an FDA-approved drug for CLL and is recognized as potentially effective in inducing remission, improving hematological parameters (blood counts), and prolonging survival in some patients, particularly when appropriately dosed. However, the statement generalizes that the treatment 'is expected' to achieve these outcomes without delineating patient-specific factors such as comorbidities, performance status, or concurrent therapy, which heavily impact these outcomes. The premise contains no details about these additional dependencies or supportive clinical evidence for these generalized expectations. Without this information, the statement cannot be definitively tied to the premise as fulfilled or contradicted; thus, the relationship is inconclusive.",
        "pred": "neutral",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "To evaluate the statement, we must consider the noted treatment (fludarabine 120mg/m\u00b2 intravenously daily for 14 days per cycle), the patient profile (70-year-old male with chronic lymphocytic leukemia, or CLL), and the expected outcomes (induction of remission, improvement in blood counts, and prolonged survival). Fludarabine is an FDA-approved drug for CLL and is recognized as potentially effective in inducing remission, improving hematological parameters (blood counts), and prolonging survival in some patients, particularly when appropriately dosed. However, the statement generalizes that the treatment 'is expected' to achieve these outcomes without delineating patient-specific factors such as comorbidities, performance status, or concurrent therapy, which heavily impact these outcomes. The premise contains no details about these additional dependencies or supportive clinical evidence for these generalized expectations. Without this information, the statement cannot be definitively tied to the premise as fulfilled or contradicted; thus, the relationship is inconclusive.",
      "pred": "neutral",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": false,
    "error_info": []
  },
  {
    "problem_id": "22",
    "pred_problem_type": "Comp",
    "reason": [
      "dose+schedule specified",
      "HER2+ diagnosis"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "55-year-old female with HER2-positive breast cancer receiving trastuzumab 40mg/kg intravenously every 3 weeks for 8 cycles.",
    "statement": "The therapy is expected to control tumor growth and improve long-term prognosis.",
    "description": "Solve compositional reasoning problem. Joint constraints over drug\u2013dose\u2013units\u2013schedule\u2013diagnosis\u2013patient factors (age, sex, renal/hepatic function, comorbidities) and co-therapy. Includes dosing bounds, indications, exclusions, and concurrency rules.",
    "label": "contradiction",
    "gt_problem_type": "risk",
    "selected_agents": [
      "compositional_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_22, ques_22 -> compositional_solver, compositional_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The premise describes a 55-year-old female with HER2-positive breast cancer who is receiving trastuzumab at a dose of 40 mg/kg intravenously every 3 weeks for 8 cycles. Trastuzumab is a well-established therapy for HER2-positive breast cancer and is generally used with the expectation of controlling tumor growth and potentially improving prognosis when used as part of an appropriate treatment regimen. However, the statement about controlling tumor growth and improving long-term prognosis involves the anticipated clinical outcomes, which are not directly stated or guaranteed in the premise. The premise provides factual details about the regimen, patient demographics, and cancer type, but it does not confirm or mention outcomes such as tumor control or prognosis improvement. Because the statement introduces assumptions about efficacy and prognosis that are not explicitly confirmed in the premise, the relationship becomes speculative and thus falls under neutrality.",
        "pred": "neutral",
        "fact_verification": "incorrect",
        "reasoning_verification": "incorrect",
        "overall_verification": false
      },
      {
        "reasoning": "The premise describes a 55-year-old female with HER2-positive breast cancer who is receiving trastuzumab at a dose of 40 mg/kg intravenously every 3 weeks for 8 cycles. However, the specified dose of 40 mg/kg is not a standard dosage for trastuzumab in the treatment of HER2-positive breast cancer. The standard regimen for intravenous administration of trastuzumab typically involves a loading dose of 8 mg/kg followed by maintenance doses of 6 mg/kg every 3 weeks. This deviation from the standard dosing undermines the expectation that the therapy described in the premise is part of a recognized and valid clinical regimen. The statement asserts that the therapy is expected to control tumor growth and improve long-term prognosis, but this assertion relies on the validity and effectiveness of the stated treatment regimen. Since the premise specifies an incorrect dosage, the causal link to expected tumor control and improved prognosis is invalidated. Thus, there is a clear mismatch and violation of dependency, as the premise contradicts the basis for the expectations outlined in the statement.",
        "pred": "contradiction"
      }
    ],
    "solution_final": {
      "reasoning": "The premise describes a 55-year-old female with HER2-positive breast cancer who is receiving trastuzumab at a dose of 40 mg/kg intravenously every 3 weeks for 8 cycles. However, the specified dose of 40 mg/kg is not a standard dosage for trastuzumab in the treatment of HER2-positive breast cancer. The standard regimen for intravenous administration of trastuzumab typically involves a loading dose of 8 mg/kg followed by maintenance doses of 6 mg/kg every 3 weeks. This deviation from the standard dosing undermines the expectation that the therapy described in the premise is part of a recognized and valid clinical regimen. The statement asserts that the therapy is expected to control tumor growth and improve long-term prognosis, but this assertion relies on the validity and effectiveness of the stated treatment regimen. Since the premise specifies an incorrect dosage, the causal link to expected tumor control and improved prognosis is invalidated. Thus, there is a clear mismatch and violation of dependency, as the premise contradicts the basis for the expectations outlined in the statement.",
      "pred": "contradiction"
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "23",
    "pred_problem_type": "Comp",
    "reason": [
      "dose+schedule constraint",
      "causal verb"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "3-year-old child diagnosed with acute myeloid leukemia receiving cytarabine 1500mg/m\u00b2 intravenously every 12 hours for 14 days.",
    "statement": "The treatment is expected to induce remission and improve the child\u2019s survival chances.",
    "description": "Solve compositional reasoning problem. Joint constraints over drug\u2013dose\u2013units\u2013schedule\u2013diagnosis\u2013patient factors (age, sex, renal/hepatic function, comorbidities) and co-therapy. Includes dosing bounds, indications, exclusions, and concurrency rules.",
    "label": "contradiction",
    "gt_problem_type": "risk",
    "selected_agents": [
      "compositional_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_23, ques_23 -> compositional_solver, compositional_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The premise describes a 3-year-old child with acute myeloid leukemia (AML) receiving cytarabine at a dose of 1500 mg/m\u00b2 intravenously every 12 hours for 14 days. The statement suggests that this treatment is expected to induce remission and improve survival. Cytarabine is a common and effective treatment in high-dose regimens for AML, and remission induction is a standard goal of therapy, matched to the child's diagnosis. While the setting aligns with therapeutic intent, the statement involves an expected clinical outcome (remission and survival improvement), which is not explicitly guaranteed in the premise. The premise does not include specific information about the child\u2019s prognosis, response likelihood, or other clinical factors affecting outcomes beyond the described treatment. Hence, the likelihood of the outcome cannot be directly verified or discounted fully from the given data.",
        "pred": "neutral",
        "fact_verification": "incorrect",
        "reasoning_verification": "correct",
        "overall_verification": false
      },
      {
        "reasoning": "The premise describes a 3-year-old child with acute myeloid leukemia (AML) receiving cytarabine at a dose of 1500 mg/m\u00b2 intravenously every 12 hours for 14 days. The statement asserts that this treatment is expected to induce remission and improve survival chances. Upon verification, the dose and schedule described in the premise are found to be unusually high and exceed standard high-dose regimens typically used in AML treatment protocols. Standard high-dose cytarabine regimens generally involve doses of 1-3 g/m\u00b2 per dose over a shorter duration, typically 4-6 days. Since the regimen in the premise is not evidence-based or consistent with clinical oncology norms, the solver's assumption about the appropriateness of the described treatment is incorrect. The claim that remission and improved survival are expected outcomes is contingent upon the treatment being appropriate and supported by clinical evidence. However, the unorthodox and unsupported dosing in the premise raises doubts about its alignment with the stated therapeutic intent. This creates a mismatch between the treatment details in the premise and the clinical expectation in the statement. Therefore, the statement is contradicted by the premise.",
        "pred": "contradiction"
      }
    ],
    "solution_final": {
      "reasoning": "The premise describes a 3-year-old child with acute myeloid leukemia (AML) receiving cytarabine at a dose of 1500 mg/m\u00b2 intravenously every 12 hours for 14 days. The statement asserts that this treatment is expected to induce remission and improve survival chances. Upon verification, the dose and schedule described in the premise are found to be unusually high and exceed standard high-dose regimens typically used in AML treatment protocols. Standard high-dose cytarabine regimens generally involve doses of 1-3 g/m\u00b2 per dose over a shorter duration, typically 4-6 days. Since the regimen in the premise is not evidence-based or consistent with clinical oncology norms, the solver's assumption about the appropriateness of the described treatment is incorrect. The claim that remission and improved survival are expected outcomes is contingent upon the treatment being appropriate and supported by clinical evidence. However, the unorthodox and unsupported dosing in the premise raises doubts about its alignment with the stated therapeutic intent. This creates a mismatch between the treatment details in the premise and the clinical expectation in the statement. Therefore, the statement is contradicted by the premise.",
      "pred": "contradiction"
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "24",
    "pred_problem_type": "Comp",
    "reason": [
      "dose+renal joint rule",
      "indication+severity"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "68-year-old male with hepatocellular carcinoma and severe liver cirrhosis (Child-Pugh C) receiving sorafenib 1600mg orally twice daily.",
    "statement": "The patient is expected to benefit from slowed tumor progression and improved overall survival.",
    "description": "Solve compositional reasoning problem. Joint constraints over drug\u2013dose\u2013units\u2013schedule\u2013diagnosis\u2013patient factors (age, sex, renal/hepatic function, comorbidities) and co-therapy. Includes dosing bounds, indications, exclusions, and concurrency rules.",
    "label": "contradiction",
    "gt_problem_type": "risk",
    "selected_agents": [
      "compositional_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_24, ques_24 -> compositional_solver, compositional_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The premise describes a 68-year-old male diagnosed with hepatocellular carcinoma and severe liver cirrhosis (Child-Pugh C) who is receiving sorafenib at a dose of 1600mg oral twice daily. Sorafenib is approved for hepatocellular carcinoma, but the dose in the premise is significantly above the standard recommended dose of 400mg twice daily (total of 800mg/day). Overdosing could exacerbate toxicity risks, especially in patients with severe liver cirrhosis, as Child-Pugh C represents a contraindicated group where sorafenib's safety and benefits are not established due to high risk of adverse effects. The statement suggests the patient is expected to benefit from slowed tumor progression and improved overall survival. However, given the extreme overdose and the contraindicated hepatic status, this combination is both unsafe and unlikely to yield the purported benefits, leading to a dependency violation.",
        "pred": "contradiction",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "The premise describes a 68-year-old male diagnosed with hepatocellular carcinoma and severe liver cirrhosis (Child-Pugh C) who is receiving sorafenib at a dose of 1600mg oral twice daily. Sorafenib is approved for hepatocellular carcinoma, but the dose in the premise is significantly above the standard recommended dose of 400mg twice daily (total of 800mg/day). Overdosing could exacerbate toxicity risks, especially in patients with severe liver cirrhosis, as Child-Pugh C represents a contraindicated group where sorafenib's safety and benefits are not established due to high risk of adverse effects. The statement suggests the patient is expected to benefit from slowed tumor progression and improved overall survival. However, given the extreme overdose and the contraindicated hepatic status, this combination is both unsafe and unlikely to yield the purported benefits, leading to a dependency violation.",
      "pred": "contradiction",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "25",
    "pred_problem_type": "Comp",
    "reason": [
      "dose+schedule context",
      "treatment-disease link"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "49-year-old female with metastatic colorectal cancer receiving irinotecan 1500mg/m\u00b2 weekly for 8 weeks.",
    "statement": "The treatment is expected to reduce metastatic lesions and improve disease control.",
    "description": "Solve compositional reasoning problem. Joint constraints over drug\u2013dose\u2013units\u2013schedule\u2013diagnosis\u2013patient factors (age, sex, renal/hepatic function, comorbidities) and co-therapy. Includes dosing bounds, indications, exclusions, and concurrency rules.",
    "label": "contradiction",
    "gt_problem_type": "risk",
    "selected_agents": [
      "compositional_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_25, ques_25 -> compositional_solver, compositional_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The premise describes a 49-year-old female with metastatic colorectal cancer receiving irinotecan at a dosage of 1500mg/m\u00b2 weekly for 8 weeks. Irinotecan is an established chemotherapeutic agent used in metastatic colorectal cancer treatment, often effective in reducing tumor size and controlling disease progression. However, the statement that the treatment is expected to reduce metastatic lesions and improve disease control introduces an implicit claim about clinical efficacy, which is context-dependent and cannot be directly inferred without verifying the dose and schedule. The stated dosage of 1500mg/m\u00b2 weekly is an exceedingly high dose, significantly above standard irinotecan dosing norms (commonly 125-180mg/m\u00b2 weekly or biweekly). Such a high dose raises severe concerns about overdose toxicity, making the described treatment regimen clinically implausible. This contradiction in the feasibility of such dosing invalidates the expectation of improved disease control.",
        "pred": "contradiction",
        "fact_verification": "incorrect",
        "reasoning_verification": "correct",
        "overall_verification": false
      },
      {
        "reasoning": "The premise describes a 49-year-old female with metastatic colorectal cancer receiving irinotecan at a dosage of 1500mg/m\u00b2 weekly for 8 weeks. Irinotecan is a recognized chemotherapeutic agent used for metastatic colorectal cancer, and standard dosing regimens generally range between 125-180mg/m\u00b2 weekly or biweekly. The statement asserts that the described treatment is expected to reduce metastatic lesions and improve disease control. However, the detailed dosage of 1500mg/m\u00b2 weekly is significantly above commonly referenced clinical dosing norms. While the verification output notes that labeling this dose as 'exceedingly high' without additional clinical evidence is speculative, this does not negate the impossibility of inferring clinical feasibility or efficacy at this dosage. In the absence of evidence or clinical guidelines supporting the efficacy or safety of this dosing schedule, the expectation of reduced metastatic lesions and disease control is not supported. The statement therefore conflicts with the premise due to this mismatch in clinical plausibility, leading to a contradiction.",
        "pred": "contradiction"
      }
    ],
    "solution_final": {
      "reasoning": "The premise describes a 49-year-old female with metastatic colorectal cancer receiving irinotecan at a dosage of 1500mg/m\u00b2 weekly for 8 weeks. Irinotecan is a recognized chemotherapeutic agent used for metastatic colorectal cancer, and standard dosing regimens generally range between 125-180mg/m\u00b2 weekly or biweekly. The statement asserts that the described treatment is expected to reduce metastatic lesions and improve disease control. However, the detailed dosage of 1500mg/m\u00b2 weekly is significantly above commonly referenced clinical dosing norms. While the verification output notes that labeling this dose as 'exceedingly high' without additional clinical evidence is speculative, this does not negate the impossibility of inferring clinical feasibility or efficacy at this dosage. In the absence of evidence or clinical guidelines supporting the efficacy or safety of this dosing schedule, the expectation of reduced metastatic lesions and disease control is not supported. The statement therefore conflicts with the premise due to this mismatch in clinical plausibility, leading to a contradiction.",
      "pred": "contradiction"
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "26",
    "pred_problem_type": "Comp",
    "reason": [
      "dose+renal joint rule",
      "multiple patient factors"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "80-year-old male with chronic kidney disease (eGFR 15 mL/min/1.73m\u00b2) and multiple myeloma receiving cisplatin 200mg/m\u00b2 daily for 5 consecutive days.",
    "statement": "The regimen is expected to achieve disease control and extend progression-free survival.",
    "description": "Solve compositional reasoning problem. Joint constraints over drug\u2013dose\u2013units\u2013schedule\u2013diagnosis\u2013patient factors (age, sex, renal/hepatic function, comorbidities) and co-therapy. Includes dosing bounds, indications, exclusions, and concurrency rules.",
    "label": "contradiction",
    "gt_problem_type": "risk",
    "selected_agents": [
      "compositional_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_26, ques_26 -> compositional_solver, compositional_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The premise specifies an 80-year-old male with chronic kidney disease (eGFR 15 mL/min/1.73m\u00b2, indicative of end-stage renal disease) and multiple myeloma receiving a cisplatin regimen of 200mg/m\u00b2 daily for 5 consecutive days. Cisplatin is known to be nephrotoxic, and its use in patients with severe renal impairment (eGFR \u226430 mL/min/1.73m\u00b2) is contraindicated due to the high risk of exacerbating renal dysfunction and other severe toxicities. The statement posits that this regimen is expected to achieve disease control and extend progression-free survival. However, the nephrotoxicity of cisplatin in this patient\u2019s clinical context (existing chronic kidney disease) makes the regimen inappropriate and potentially harmful, contradicting the possibility of achieving disease control or therapeutic benefit. The dependencies between the patient's renal function, the drug's toxicity profile, and its intended therapeutic effect result in a violation of safety and feasibility, rendering the statement in contradiction with the premise.",
        "pred": "contradiction",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "The premise specifies an 80-year-old male with chronic kidney disease (eGFR 15 mL/min/1.73m\u00b2, indicative of end-stage renal disease) and multiple myeloma receiving a cisplatin regimen of 200mg/m\u00b2 daily for 5 consecutive days. Cisplatin is known to be nephrotoxic, and its use in patients with severe renal impairment (eGFR \u226430 mL/min/1.73m\u00b2) is contraindicated due to the high risk of exacerbating renal dysfunction and other severe toxicities. The statement posits that this regimen is expected to achieve disease control and extend progression-free survival. However, the nephrotoxicity of cisplatin in this patient\u2019s clinical context (existing chronic kidney disease) makes the regimen inappropriate and potentially harmful, contradicting the possibility of achieving disease control or therapeutic benefit. The dependencies between the patient's renal function, the drug's toxicity profile, and its intended therapeutic effect result in a violation of safety and feasibility, rendering the statement in contradiction with the premise.",
      "pred": "contradiction",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "27",
    "pred_problem_type": "Comp",
    "reason": [
      "carboplatin AUC 20",
      "dose+schedule+cycles"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "62-year-old female with ovarian cancer receiving carboplatin at an AUC of 20 every 3 weeks for 6 cycles.",
    "statement": "The treatment is expected to shrink tumor burden and prolong overall survival.",
    "description": "Solve compositional reasoning problem. Joint constraints over drug\u2013dose\u2013units\u2013schedule\u2013diagnosis\u2013patient factors (age, sex, renal/hepatic function, comorbidities) and co-therapy. Includes dosing bounds, indications, exclusions, and concurrency rules.",
    "label": "contradiction",
    "gt_problem_type": "risk",
    "selected_agents": [
      "compositional_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_27, ques_27 -> compositional_solver, compositional_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The premise describes a 62-year-old female with ovarian cancer receiving carboplatin at an AUC (area under the curve, a pharmacokinetic dosing strategy) of 20 every 3 weeks for 6 cycles. This dosage is unusually high compared to standard carboplatin doses in ovarian cancer treatment, where the typical AUC ranges from 4 to 6 per cycle. Such a high dose raises concerns for excessive toxicity, making it likely that the treatment could cause severe adverse effects rather than achieving the therapeutic goals of shrinking tumor burden and improving survival. Therefore, the statement that the treatment is expected to shrink the tumor burden and prolong survival contradicts the implications of the premise due to the unreasonably high dosing, which violates dosing standards and undermines the assumption of efficacy.",
        "pred": "contradiction",
        "fact_verification": "incorrect",
        "reasoning_verification": "incorrect",
        "overall_verification": false
      },
      {
        "reasoning": "The premise describes a 62-year-old female with ovarian cancer receiving carboplatin at an AUC of 20 every 3 weeks for 6 cycles. The statement asserts that the treatment is expected to shrink tumor burden and prolong overall survival. Evaluating this under clinical norms, an AUC of 20 is significantly higher than the typical range for carboplatin dosing in ovarian cancer treatment, which is usually between AUC 4 and 6 per cycle. While this high dosing raises concerns about increased toxicity, the premise itself does not provide specific information regarding the patient's response to treatment, toxicity outcomes, or other clinical factors like tolerability. Thus, we cannot definitively conclude failure in achieving the stated therapeutic goals of shrinking tumor burden and prolonging survival based solely on the high dosing level. Given the lack of decisive evidence related to the patient's response and the incomplete fulfillment of all-conditions analysis, the statement remains indeterminate in its relationship to the premise. Therefore, the appropriate label is 'neutral.'",
        "pred": "neutral"
      }
    ],
    "solution_final": {
      "reasoning": "The premise describes a 62-year-old female with ovarian cancer receiving carboplatin at an AUC of 20 every 3 weeks for 6 cycles. The statement asserts that the treatment is expected to shrink tumor burden and prolong overall survival. Evaluating this under clinical norms, an AUC of 20 is significantly higher than the typical range for carboplatin dosing in ovarian cancer treatment, which is usually between AUC 4 and 6 per cycle. While this high dosing raises concerns about increased toxicity, the premise itself does not provide specific information regarding the patient's response to treatment, toxicity outcomes, or other clinical factors like tolerability. Thus, we cannot definitively conclude failure in achieving the stated therapeutic goals of shrinking tumor burden and prolonging survival based solely on the high dosing level. Given the lack of decisive evidence related to the patient's response and the incomplete fulfillment of all-conditions analysis, the statement remains indeterminate in its relationship to the premise. Therefore, the appropriate label is 'neutral.'",
      "pred": "neutral"
    },
    "is_correct": false,
    "error_info": []
  },
  {
    "problem_id": "28",
    "pred_problem_type": "Comp",
    "reason": [
      "dose+schedule constraint",
      "causal verb"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "58-year-old male with small cell lung cancer receiving etoposide 1500mg/m\u00b2 daily for 10 consecutive days.",
    "statement": "The regimen is expected to induce tumor regression and improve clinical outcomes.",
    "description": "Solve compositional reasoning problem. Joint constraints over drug\u2013dose\u2013units\u2013schedule\u2013diagnosis\u2013patient factors (age, sex, renal/hepatic function, comorbidities) and co-therapy. Includes dosing bounds, indications, exclusions, and concurrency rules.",
    "label": "contradiction",
    "gt_problem_type": "risk",
    "selected_agents": [
      "compositional_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_28, ques_28 -> compositional_solver, compositional_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The premise describes a 58-year-old male with small cell lung cancer being treated with etoposide at a dose of 1500mg/m\u00b2 daily for 10 consecutive days. The statement predicts that this regimen will induce tumor regression and improve clinical outcomes. First, the dose provided in the premise (1500mg/m\u00b2) significantly exceeds standard guidelines for etoposide, where common doses range from 80-120mg/m\u00b2 daily depending on the regimen. Such a high dose introduces concerns regarding safety and feasibility, potentially causing severe toxicity rather than therapeutic benefits. Thus, the excessive dose undermines the claim that the regimen is expected to improve clinical outcomes. Additionally, there is no explicit confirmation in the premise of clinical evidence supporting this specific regimen's efficacy. As a result, the combination of an unreasonably high dose contradicts the mechanism implied in the statement, which assumes improvements in clinical outcomes. Therefore, the prediction described in the statement is contradicted by the premise due to a mismatch in the dose's plausibility and its anticipated efficacy.",
        "pred": "contradiction",
        "fact_verification": "incorrect",
        "reasoning_verification": "correct",
        "overall_verification": false
      },
      {
        "reasoning": "The premise describes a 58-year-old male with small cell lung cancer being treated with etoposide at a dose of 1500mg/m\u00b2 daily for 10 consecutive days. The statement claims that this regimen is expected to induce tumor regression and improve clinical outcomes. Upon verification, it was clarified that while etoposide dosing can vary depending on the regimen and cancer type, doses for small cell lung cancer rarely exceed 200mg/m\u00b2 daily per clinical guidelines. The dose of 1500mg/m\u00b2 daily mentioned in the premise is unusually high, raising significant concerns regarding safety and potential toxicity. This extreme dosing undermines the plausibility of achieving tumor regression and improved clinical outcomes, as severe toxicity would likely outweigh potential therapeutic benefits. The corrected facts and the reasoning pattern confirm that the excessive dose in the premise critically mismatches the statement\u2019s assumption, leading to a contradiction between the regimen described and the expected clinical outcomes.",
        "pred": "contradiction"
      }
    ],
    "solution_final": {
      "reasoning": "The premise describes a 58-year-old male with small cell lung cancer being treated with etoposide at a dose of 1500mg/m\u00b2 daily for 10 consecutive days. The statement claims that this regimen is expected to induce tumor regression and improve clinical outcomes. Upon verification, it was clarified that while etoposide dosing can vary depending on the regimen and cancer type, doses for small cell lung cancer rarely exceed 200mg/m\u00b2 daily per clinical guidelines. The dose of 1500mg/m\u00b2 daily mentioned in the premise is unusually high, raising significant concerns regarding safety and potential toxicity. This extreme dosing undermines the plausibility of achieving tumor regression and improved clinical outcomes, as severe toxicity would likely outweigh potential therapeutic benefits. The corrected facts and the reasoning pattern confirm that the excessive dose in the premise critically mismatches the statement\u2019s assumption, leading to a contradiction between the regimen described and the expected clinical outcomes.",
      "pred": "contradiction"
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "29",
    "pred_problem_type": "Comp",
    "reason": [
      "causal verb",
      "dose+diagnosis+age joint rule"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "4-month-old infant diagnosed with neuroblastoma receiving doxorubicin 80mg/m\u00b2 daily for 7 days.",
    "statement": "The treatment is expected to achieve tumor shrinkage and improve prognosis.",
    "description": "Solve compositional reasoning problem. Joint constraints over drug\u2013dose\u2013units\u2013schedule\u2013diagnosis\u2013patient factors (age, sex, renal/hepatic function, comorbidities) and co-therapy. Includes dosing bounds, indications, exclusions, and concurrency rules.",
    "label": "contradiction",
    "gt_problem_type": "risk",
    "selected_agents": [
      "compositional_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_29, ques_29 -> compositional_solver, compositional_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "To evaluate the statement, factors such as patient age, diagnosis, intervention, schedule, dosing, and anticipated outcomes must be considered. The premise specifies a 4-month-old infant with neuroblastoma receiving doxorubicin at a dose of 80mg/m\u00b2 daily over 7 days. Neuroblastoma is a type of cancer treated with certain chemotherapeutic regimens, which may include doxorubicin. For infants, dosing is typically adjusted based on body surface area to balance efficacy and safety. Doxorubicin is a cytotoxic agent that can facilitate tumor shrinkage, which is a reasonable expectation in a treatment plan for neuroblastoma. Improving the prognosis is context-dependent and involves various factors such as response to therapy, tumor biology, and overall treatment strategy. However, the language of the statement does not conflict with the premise or impose additional implausible or contradictory constraints. Since there are no dependency violations, mismatches, or contraindications explicitly present, the statement aligns with clinical expectations based on the premise.",
        "pred": "entailment",
        "fact_verification": "incorrect",
        "reasoning_verification": "incorrect",
        "overall_verification": false
      },
      {
        "reasoning": "The premise specifies that a 4-month-old infant with neuroblastoma is receiving doxorubicin at a dosage of 80mg/m\u00b2 daily for 7 days. Evaluating the statement requires analyzing factors such as patient age, diagnosis, intervention, dosing schedule, and expected outcomes. Neuroblastoma is a type of cancer in which chemotherapy, including doxorubicin, is used as part of treatment. However, the dosing details in the premise raise significant concerns. For pediatric patients, especially infants, doxorubicin dosages are carefully calculated to avoid toxicity, particularly cardiotoxicity, and the cumulative lifetime dose is typically limited to 300-450 mg/m\u00b2. A daily dose of 80mg/m\u00b2 over 7 days, resulting in a total dose of 560mg/m\u00b2 within a single treatment cycle, far exceeds established clinical safety limits and is not a standard or plausible chemotherapy regimen for this patient population. This excessive and clinically unsupported dosing schedule introduces a direct contradiction to the reasonable expectation that the treatment would shrink the tumor and improve prognosis. The dosage would likely result in severe toxicity, negating the likelihood of a favorable therapeutic outcome. The statement contradicts the premise due to the stated dosing schedule being incompatible with recognized safety and efficacy standards in pediatric oncology.",
        "pred": "contradiction"
      }
    ],
    "solution_final": {
      "reasoning": "The premise specifies that a 4-month-old infant with neuroblastoma is receiving doxorubicin at a dosage of 80mg/m\u00b2 daily for 7 days. Evaluating the statement requires analyzing factors such as patient age, diagnosis, intervention, dosing schedule, and expected outcomes. Neuroblastoma is a type of cancer in which chemotherapy, including doxorubicin, is used as part of treatment. However, the dosing details in the premise raise significant concerns. For pediatric patients, especially infants, doxorubicin dosages are carefully calculated to avoid toxicity, particularly cardiotoxicity, and the cumulative lifetime dose is typically limited to 300-450 mg/m\u00b2. A daily dose of 80mg/m\u00b2 over 7 days, resulting in a total dose of 560mg/m\u00b2 within a single treatment cycle, far exceeds established clinical safety limits and is not a standard or plausible chemotherapy regimen for this patient population. This excessive and clinically unsupported dosing schedule introduces a direct contradiction to the reasonable expectation that the treatment would shrink the tumor and improve prognosis. The dosage would likely result in severe toxicity, negating the likelihood of a favorable therapeutic outcome. The statement contradicts the premise due to the stated dosing schedule being incompatible with recognized safety and efficacy standards in pediatric oncology.",
      "pred": "contradiction"
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "30",
    "pred_problem_type": "Comp",
    "reason": [
      "dose+schedule dependency",
      "causal verb"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "67-year-old patient with advanced gastric cancer receiving 5-fluorouracil 2500mg/m\u00b2 intravenously daily for 14 consecutive days.",
    "statement": "The therapy is expected to slow disease progression and improve survival rates.",
    "description": "Solve compositional reasoning problem. Joint constraints over drug\u2013dose\u2013units\u2013schedule\u2013diagnosis\u2013patient factors (age, sex, renal/hepatic function, comorbidities) and co-therapy. Includes dosing bounds, indications, exclusions, and concurrency rules.",
    "label": "contradiction",
    "gt_problem_type": "risk",
    "selected_agents": [
      "compositional_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_30, ques_30 -> compositional_solver, compositional_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The premise describes a 67-year-old patient with advanced gastric cancer receiving 5-fluorouracil at a dose of 2500mg/m\u00b2 intravenously daily for 14 days. The statement mentions that this therapy is expected to slow disease progression and improve survival rates. While 5-fluorouracil is a well-documented chemotherapy agent used in the treatment of gastric cancer, the statement's claims about expected outcomes (slowing progression and improving survival rates) represent general clinical expectations but are not explicitly stated or confirmed in the premise. Further, outcomes often depend on individual patient factors (e.g., performance status, comorbidities, genetic factors), which are not addressed in the premise. Because the premise neither explicitly supports nor contradicts the outcomes mentioned, and individual variability in drug response introduces uncertainty, this leads to a neutral interpretation.",
        "pred": "neutral",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "The premise describes a 67-year-old patient with advanced gastric cancer receiving 5-fluorouracil at a dose of 2500mg/m\u00b2 intravenously daily for 14 days. The statement mentions that this therapy is expected to slow disease progression and improve survival rates. While 5-fluorouracil is a well-documented chemotherapy agent used in the treatment of gastric cancer, the statement's claims about expected outcomes (slowing progression and improving survival rates) represent general clinical expectations but are not explicitly stated or confirmed in the premise. Further, outcomes often depend on individual patient factors (e.g., performance status, comorbidities, genetic factors), which are not addressed in the premise. Because the premise neither explicitly supports nor contradicts the outcomes mentioned, and individual variability in drug response introduces uncertainty, this leads to a neutral interpretation.",
      "pred": "neutral",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": false,
    "error_info": []
  },
  {
    "problem_id": "31",
    "pred_problem_type": "Risk",
    "reason": [
      "risk superlative",
      "diarrhea frequency"
    ],
    "goal": "Solve the reasoning problem",
    "premise": [
      "Adverse Events 9:",
      " Total: 48/72 (66.67%)",
      " Diarrhea 30/72 (41.67%)",
      " Neutropenic sepsis 3/72 (4.17%)",
      " Gastrointestinal bleeding 2/72 (2.78%)",
      " Hypokalemia 4/72 (5.56%)",
      " Injection site reaction 6/72 (8.33%)",
      " Pulmonary embolism 2/72 (2.78%)"
    ],
    "statement": "The highest patient risk was associated with the occurrence of diarrhea.",
    "description": "Solve risk reasoning problem. Risk ranking or comparison (highest risk, safer, dangerous), weighing severity against frequency, expected-harm reasoning, and hazards not ruled out by the premise.",
    "label": "contradiction",
    "gt_problem_type": "risk",
    "selected_agents": [
      "risk_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_31, ques_31 -> risk_solver, risk_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "From the premise, adverse events include diarrhea (41.67%), neutropenic sepsis (4.17%), gastrointestinal bleeding (2.78%), hypokalemia (5.56%), injection site reaction (8.33%), and pulmonary embolism (2.78%). To determine the 'highest patient risk,' the core principle of expected harm (likelihood \u00d7 severity) must be used rather than just raw frequency. Diarrhea is the most frequent (41.67%) but is generally a lower-severity condition compared to life-threatening events like neutropenic sepsis (4.17%) and pulmonary embolism (2.78%), which involve significantly higher severity due to their potential to cause organ failure or death. Therefore, while diarrhea is the most common event, it does not pose the highest patient risk when considering both likelihood and severity. The statement incorrectly prioritizes frequency over overall patient risk. Thus, the statement is contradicted by the premise information.",
        "pred": "contradiction",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "From the premise, adverse events include diarrhea (41.67%), neutropenic sepsis (4.17%), gastrointestinal bleeding (2.78%), hypokalemia (5.56%), injection site reaction (8.33%), and pulmonary embolism (2.78%). To determine the 'highest patient risk,' the core principle of expected harm (likelihood \u00d7 severity) must be used rather than just raw frequency. Diarrhea is the most frequent (41.67%) but is generally a lower-severity condition compared to life-threatening events like neutropenic sepsis (4.17%) and pulmonary embolism (2.78%), which involve significantly higher severity due to their potential to cause organ failure or death. Therefore, while diarrhea is the most common event, it does not pose the highest patient risk when considering both likelihood and severity. The statement incorrectly prioritizes frequency over overall patient risk. Thus, the statement is contradicted by the premise information.",
      "pred": "contradiction",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "32",
    "pred_problem_type": "Risk",
    "reason": [
      "risk superlative",
      "frequency comparison"
    ],
    "goal": "Solve the reasoning problem",
    "premise": [
      "Adverse Events 10:",
      " Total: 42/66 (63.64%)",
      " Fever 22/66 (33.33%)",
      " Anaphylaxis 2/66 (3.03%)",
      " Ischemic stroke 1/66 (1.52%)",
      " Atrial fibrillation 3/66 (4.55%)",
      " Hypotension 4/66 (6.06%)",
      " Nausea 5/66 (7.58%)"
    ],
    "statement": "The highest patient risk was associated with the occurrence of fever.",
    "description": "Solve risk reasoning problem. Risk ranking or comparison (highest risk, safer, dangerous), weighing severity against frequency, expected-harm reasoning, and hazards not ruled out by the premise.",
    "label": "contradiction",
    "gt_problem_type": "risk",
    "selected_agents": [
      "risk_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_32, ques_32 -> risk_solver, risk_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The premise reports various adverse events and their frequencies. Fever occurred in 22 out of 66 patients (33.33%), making it the most common adverse event. However, 'highest patient risk' involves not just likelihood but also severity. Comparing fever (likelihood: high, severity: minor to moderate) with ischemic stroke (likelihood: very low at 1.52%, severity: life-threatening), anaphylaxis (likelihood: rare at 3.03%, severity: potentially life-threatening), and atrial fibrillation (likelihood: rare at 4.55%, severity: serious), the highest patient risk is likely not associated with fever due to its lower severity relative to these rare but severe conditions. Thus, the statement that the highest risk was associated with fever is contradicted by the comparative risk assessment.",
        "pred": "contradiction",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "The premise reports various adverse events and their frequencies. Fever occurred in 22 out of 66 patients (33.33%), making it the most common adverse event. However, 'highest patient risk' involves not just likelihood but also severity. Comparing fever (likelihood: high, severity: minor to moderate) with ischemic stroke (likelihood: very low at 1.52%, severity: life-threatening), anaphylaxis (likelihood: rare at 3.03%, severity: potentially life-threatening), and atrial fibrillation (likelihood: rare at 4.55%, severity: serious), the highest patient risk is likely not associated with fever due to its lower severity relative to these rare but severe conditions. Thus, the statement that the highest risk was associated with fever is contradicted by the comparative risk assessment.",
      "pred": "contradiction",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "33",
    "pred_problem_type": "Risk",
    "reason": [
      "risk superlative",
      "highest risk comparison"
    ],
    "goal": "Solve the reasoning problem",
    "premise": [
      "Adverse Events 11:",
      " Total: 36/58 (62.07%)",
      " Rash 18/58 (31.03%)",
      " Stevens-Johnson syndrome 1/58 (1.72%)",
      " Acute hepatic failure 2/58 (3.45%)",
      " Elevated liver enzymes 5/58 (8.62%)",
      " Pruritus 7/58 (12.07%)",
      " Headache 4/58 (6.90%)"
    ],
    "statement": "The highest patient risk was associated with the occurrence of rash.",
    "description": "Solve risk reasoning problem. Risk ranking or comparison (highest risk, safer, dangerous), weighing severity against frequency, expected-harm reasoning, and hazards not ruled out by the premise.",
    "label": "contradiction",
    "gt_problem_type": "risk",
    "selected_agents": [
      "risk_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_33, ques_33 -> risk_solver, risk_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "Based on the premise, we observe the frequency of various adverse events and their severity. Rash occurred in 31.03% of cases, making it the most frequent adverse event. However, its severity is not as high as other reported adverse events such as Stevens-Johnson syndrome (1.72%) or acute hepatic failure (3.45%). Stevens-Johnson syndrome is a life-threatening condition, and acute hepatic failure can also have severe consequences, including organ failure and death. The statement claims that 'the highest patient risk was associated with the occurrence of rash.' Considering the principles of comparative risk assessment, while rash is the most frequent, the likelihood \u00d7 severity for events like Stevens-Johnson syndrome and acute hepatic failure would outweigh rash due to significantly higher severity, even if their occurrence rates are lower. Thus, the statement is contradicted by the evidence.",
        "pred": "contradiction",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "Based on the premise, we observe the frequency of various adverse events and their severity. Rash occurred in 31.03% of cases, making it the most frequent adverse event. However, its severity is not as high as other reported adverse events such as Stevens-Johnson syndrome (1.72%) or acute hepatic failure (3.45%). Stevens-Johnson syndrome is a life-threatening condition, and acute hepatic failure can also have severe consequences, including organ failure and death. The statement claims that 'the highest patient risk was associated with the occurrence of rash.' Considering the principles of comparative risk assessment, while rash is the most frequent, the likelihood \u00d7 severity for events like Stevens-Johnson syndrome and acute hepatic failure would outweigh rash due to significantly higher severity, even if their occurrence rates are lower. Thus, the statement is contradicted by the evidence.",
      "pred": "contradiction",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "34",
    "pred_problem_type": "Risk",
    "reason": [
      "risk superlative",
      "highest risk claim"
    ],
    "goal": "Solve the reasoning problem",
    "premise": [
      "Adverse Events 12:",
      " Total: 44/64 (68.75%)",
      " Cough 19/64 (29.69%)",
      " Pneumonitis 4/64 (6.25%)",
      " Respiratory failure 2/64 (3.13%)",
      " Sepsis 3/64 (4.69%)",
      " Hyponatremia 5/64 (7.81%)",
      " Dizziness 6/64 (9.38%)"
    ],
    "statement": "The highest patient risk was associated with the occurrence of cough.",
    "description": "Solve risk reasoning problem. Risk ranking or comparison (highest risk, safer, dangerous), weighing severity against frequency, expected-harm reasoning, and hazards not ruled out by the premise.",
    "label": "contradiction",
    "gt_problem_type": "risk",
    "selected_agents": [
      "risk_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_34, ques_34 -> risk_solver, risk_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "From the premise, cough occurred in 29.69% of patients, the highest frequency among listed adverse events. However, evaluating patient risk requires consideration of both likelihood (frequency) and severity. While cough is the most common event, its clinical severity is generally minor to moderate. In contrast, conditions like respiratory failure (3.13%), sepsis (4.69%), and pneumonitis (6.25%) have significantly greater severity, involving life-threatening or serious complications. The statement claims that the highest patient risk is associated with the occurrence of cough, but this fails to integrate the higher severity of other less frequent events, such as respiratory failure or sepsis. Therefore, based on the comparative risk computation, the statement contradicts the evidence presented in the premise.",
        "pred": "contradiction",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "From the premise, cough occurred in 29.69% of patients, the highest frequency among listed adverse events. However, evaluating patient risk requires consideration of both likelihood (frequency) and severity. While cough is the most common event, its clinical severity is generally minor to moderate. In contrast, conditions like respiratory failure (3.13%), sepsis (4.69%), and pneumonitis (6.25%) have significantly greater severity, involving life-threatening or serious complications. The statement claims that the highest patient risk is associated with the occurrence of cough, but this fails to integrate the higher severity of other less frequent events, such as respiratory failure or sepsis. Therefore, based on the comparative risk computation, the statement contradicts the evidence presented in the premise.",
      "pred": "contradiction",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "35",
    "pred_problem_type": "Risk",
    "reason": [
      "risk superlative",
      "highest patient risk"
    ],
    "goal": "Solve the reasoning problem",
    "premise": [
      "Adverse Events 13:",
      " Total: 60/90 (66.67%)",
      " Arthralgia 28/90 (31.11%)",
      " Torsades de pointes 1/90 (1.11%)",
      " Ventricular tachycardia 2/90 (2.22%)",
      " Pancreatitis 3/90 (3.33%)",
      " Acute kidney injury 5/90 (5.56%)",
      " Fatigue 10/90 (11.11%)"
    ],
    "statement": "The highest patient risk was associated with the occurrence of arthralgia.",
    "description": "Solve risk reasoning problem. Risk ranking or comparison (highest risk, safer, dangerous), weighing severity against frequency, expected-harm reasoning, and hazards not ruled out by the premise.",
    "label": "contradiction",
    "gt_problem_type": "risk",
    "selected_agents": [
      "risk_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_35, ques_35 -> risk_solver, risk_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The premise lists several adverse events along with their respective frequencies among patients, with arthralgia occurring in 28/90 (31.11%) patients, making it the most common event. However, arthralgia is typically a moderate condition, and its severity is significantly lower compared to other listed adverse events such as Torsades de Pointes (1/90, 1.11%), which is life-threatening due to its potential to cause sudden cardiac death, or acute kidney injury (5/90, 5.56%), which can involve organ dysfunction. For risk assessment (likelihood \u00d7 severity), life-threatening or severe adverse events, even with lower frequency, often outweigh common but less severe events. Hence, the statement that the highest patient risk was associated with arthralgia is contradicted, as higher-severity events like Torsades de Pointes or acute kidney injury pose greater overall risk, despite their lower likelihood.",
        "pred": "contradiction",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "The premise lists several adverse events along with their respective frequencies among patients, with arthralgia occurring in 28/90 (31.11%) patients, making it the most common event. However, arthralgia is typically a moderate condition, and its severity is significantly lower compared to other listed adverse events such as Torsades de Pointes (1/90, 1.11%), which is life-threatening due to its potential to cause sudden cardiac death, or acute kidney injury (5/90, 5.56%), which can involve organ dysfunction. For risk assessment (likelihood \u00d7 severity), life-threatening or severe adverse events, even with lower frequency, often outweigh common but less severe events. Hence, the statement that the highest patient risk was associated with arthralgia is contradicted, as higher-severity events like Torsades de Pointes or acute kidney injury pose greater overall risk, despite their lower likelihood.",
      "pred": "contradiction",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "36",
    "pred_problem_type": "Risk",
    "reason": [
      "hazard not ruled out",
      "urgency implied"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "A 38-year-old woman reports an abrupt 'worst headache of my life' that began during a high-intensity spin class, followed by brief nausea and neck stiffness. She is alert and oriented with no focal neurological deficits on examination. She has not yet had any neuroimaging or lumbar puncture.",
    "statement": "Subarachnoid hemorrhage must be urgently excluded.",
    "description": "Solve risk reasoning problem. Risk ranking or comparison (highest risk, safer, dangerous), weighing severity against frequency, expected-harm reasoning, and hazards not ruled out by the premise.",
    "label": "entailment",
    "gt_problem_type": "risk",
    "selected_agents": [
      "risk_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_36, ques_36 -> risk_solver, risk_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The candidate adverse event or plausible latent diagnosis (B) in this context is a subarachnoid hemorrhage (SAH). The patient reports a 'worst headache of my life' that began abruptly during high-intensity exertion, accompanied by transient nausea and neck stiffness. These are classic symptoms associated with SAH, a life-threatening condition if untreated. Although she is currently alert, oriented, and without focal neurological deficits, these do not exclude the possibility of SAH, as early stages may lack these severe findings. No neuroimaging or lumbar puncture has been performed yet, meaning a definitive exclusion of SAH has not occurred. Given the severity (life-threatening potential) and plausible likelihood derived from the symptoms and clinical setting, it is essential to urgently exclude this condition via appropriate diagnostic tests. The statement correctly emphasizes the need to rule out SAH based on the risk profile and aligns with the principle of prioritizing life-threatening conditions. Therefore, the statement is entailed.",
        "pred": "entailment",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "The candidate adverse event or plausible latent diagnosis (B) in this context is a subarachnoid hemorrhage (SAH). The patient reports a 'worst headache of my life' that began abruptly during high-intensity exertion, accompanied by transient nausea and neck stiffness. These are classic symptoms associated with SAH, a life-threatening condition if untreated. Although she is currently alert, oriented, and without focal neurological deficits, these do not exclude the possibility of SAH, as early stages may lack these severe findings. No neuroimaging or lumbar puncture has been performed yet, meaning a definitive exclusion of SAH has not occurred. Given the severity (life-threatening potential) and plausible likelihood derived from the symptoms and clinical setting, it is essential to urgently exclude this condition via appropriate diagnostic tests. The statement correctly emphasizes the need to rule out SAH based on the risk profile and aligns with the principle of prioritizing life-threatening conditions. Therefore, the statement is entailed.",
      "pred": "entailment",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "37",
    "pred_problem_type": "Epist",
    "reason": [
      "mixed evidence",
      "diagnostic exclusion"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "A 27-year-old woman presents with lower abdominal pain predominantly on the right, light vaginal spotting, and new shoulder-tip pain. Last menstrual period was approximately 6 weeks ago. She feels lightheaded when standing but is hemodynamically stable. No pregnancy test or imaging has been done yet.",
    "statement": "Urgent pelvic ultrasound and quantitative \u03b2-hCG testing are required to exclude ectopic pregnancy.",
    "description": "Solve epistemic reasoning problem. Determining what is true from mixed or conflicting evidence within the premise. Includes resolution of contradictions between sources, preferring objective measurements (labs, imaging) over opinions, and establishing diagnostic status from an evidence hierarchy.",
    "label": "entailment",
    "gt_problem_type": "risk",
    "selected_agents": [
      "epistemic_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_37, ques_37 -> epistemic_solver, epistemic_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The premise describes a 27-year-old woman with symptoms suspicious for ectopic pregnancy, including lower abdominal pain predominantly on the right, light vaginal spotting, and new shoulder-tip pain, which raises concern for potential intraperitoneal bleeding. Her last menstrual period was 6 weeks ago, which is consistent with early pregnancy, and she also reports lightheadedness on standing. While no pregnancy test or imaging has been conducted yet, the clinical picture warrants urgent evaluation because ectopic pregnancy can be life-threatening. The statement proposes the need for urgent pelvic ultrasound and quantitative \u03b2-hCG testing, which are standard diagnostic tools for assessing ectopic pregnancy. The need for these tests is consistent with the clinical presentation and no conflicting or contradictory evidence exists in the premise. The evidence aligns with the recommendation, making the statement fully supported by the premise.",
        "pred": "entailment",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "The premise describes a 27-year-old woman with symptoms suspicious for ectopic pregnancy, including lower abdominal pain predominantly on the right, light vaginal spotting, and new shoulder-tip pain, which raises concern for potential intraperitoneal bleeding. Her last menstrual period was 6 weeks ago, which is consistent with early pregnancy, and she also reports lightheadedness on standing. While no pregnancy test or imaging has been conducted yet, the clinical picture warrants urgent evaluation because ectopic pregnancy can be life-threatening. The statement proposes the need for urgent pelvic ultrasound and quantitative \u03b2-hCG testing, which are standard diagnostic tools for assessing ectopic pregnancy. The need for these tests is consistent with the clinical presentation and no conflicting or contradictory evidence exists in the premise. The evidence aligns with the recommendation, making the statement fully supported by the premise.",
      "pred": "entailment",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "38",
    "pred_problem_type": "Risk",
    "reason": [
      "urgent exclusion",
      "hazard not ruled out"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "A 34-year-old woman, two weeks postpartum, presents with sudden pleuritic chest pain and shortness of breath. Heart rate is 118 bpm, SpO2 92% on room air, and she reports mild calf discomfort after prolonged car travel yesterday. Chest auscultation is clear and a prior chest X-ray from triage was unremarkable. No D-dimer or CT pulmonary angiography has been performed.",
    "statement": "Pulmonary embolism requires urgent exclusion.",
    "description": "Solve risk reasoning problem. Risk ranking or comparison (highest risk, safer, dangerous), weighing severity against frequency, expected-harm reasoning, and hazards not ruled out by the premise.",
    "label": "entailment",
    "gt_problem_type": "risk",
    "selected_agents": [
      "risk_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_38, ques_38 -> risk_solver, risk_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The premise describes a 34-year-old postpartum woman with pleuritic chest pain, shortness of breath, tachycardia, and borderline hypoxemia on room air (SpO2 92%). Postpartum status places her at an elevated risk for venous thromboembolism, which is further supported by recent calf discomfort after prolonged travel, a known risk factor for deep vein thrombosis (DVT) and pulmonary embolism (PE). Although chest auscultation is clear and her chest X-ray from triage is unremarkable, these findings do not rule out PE. The absence of completed diagnostic tests (e.g., D-dimer, CT pulmonary angiography) keeps PE as a plausible and serious latent diagnosis. PE is potentially life-threatening if untreated, with risks of sudden hemodynamic collapse, severe hypoxemia, and death. As such, ruling out or confirming PE promptly is critical to mitigate this severe hazard. The statement asserts that PE requires urgent exclusion, and given the premise and associated risks, this is supported. The comparison of likelihood \u00d7 severity justifies urgency in excluding PE.",
        "pred": "entailment",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "The premise describes a 34-year-old postpartum woman with pleuritic chest pain, shortness of breath, tachycardia, and borderline hypoxemia on room air (SpO2 92%). Postpartum status places her at an elevated risk for venous thromboembolism, which is further supported by recent calf discomfort after prolonged travel, a known risk factor for deep vein thrombosis (DVT) and pulmonary embolism (PE). Although chest auscultation is clear and her chest X-ray from triage is unremarkable, these findings do not rule out PE. The absence of completed diagnostic tests (e.g., D-dimer, CT pulmonary angiography) keeps PE as a plausible and serious latent diagnosis. PE is potentially life-threatening if untreated, with risks of sudden hemodynamic collapse, severe hypoxemia, and death. As such, ruling out or confirming PE promptly is critical to mitigate this severe hazard. The statement asserts that PE requires urgent exclusion, and given the premise and associated risks, this is supported. The comparison of likelihood \u00d7 severity justifies urgency in excluding PE.",
      "pred": "entailment",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "39",
    "pred_problem_type": "Risk",
    "reason": [
      "exclude hazard",
      "unruled syndrome"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "A 55-year-old man with acute severe low back pain reports numbness in the perineal ('saddle') area, difficulty initiating urination, and bilateral leg weakness that worsened over 12 hours. Reflexes are reduced at the ankles. He has not had any spinal imaging or bladder scan yet.",
    "statement": "Emergency MRI of the lumbosacral spine is required to exclude cauda equina syndrome.",
    "description": "Solve risk reasoning problem. Risk ranking or comparison (highest risk, safer, dangerous), weighing severity against frequency, expected-harm reasoning, and hazards not ruled out by the premise.",
    "label": "entailment",
    "gt_problem_type": "risk",
    "selected_agents": [
      "risk_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_39, ques_39 -> risk_solver, risk_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "The premise describes a 55-year-old man with acute, severe low back pain, numbness in the saddle area, difficulty initiating urination, and bilateral leg weakness that progressed over 12 hours, along with reduced ankle reflexes. These symptoms are strongly suggestive of cauda equina syndrome (CES), a rare but catastrophic condition that can lead to permanent neurological deficits if not treated promptly. A severe latent diagnosis such as CES cannot be definitively ruled out without imaging (e.g., MRI of the lumbosacral spine) to evaluate nerve root compression, especially given the absence of spinal imaging or bladder scan. Delaying imaging poses a substantial risk of irreversible harm, such as paralysis, incontinence, or sexual dysfunction. Emergency MRI is thus the correct and urgently required action to exclude CES or confirm the diagnosis for further management. The statement aligns with the highest priority of evaluating and mitigating severe risk.",
        "pred": "entailment",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "The premise describes a 55-year-old man with acute, severe low back pain, numbness in the saddle area, difficulty initiating urination, and bilateral leg weakness that progressed over 12 hours, along with reduced ankle reflexes. These symptoms are strongly suggestive of cauda equina syndrome (CES), a rare but catastrophic condition that can lead to permanent neurological deficits if not treated promptly. A severe latent diagnosis such as CES cannot be definitively ruled out without imaging (e.g., MRI of the lumbosacral spine) to evaluate nerve root compression, especially given the absence of spinal imaging or bladder scan. Delaying imaging poses a substantial risk of irreversible harm, such as paralysis, incontinence, or sexual dysfunction. Emergency MRI is thus the correct and urgently required action to exclude CES or confirm the diagnosis for further management. The statement aligns with the highest priority of evaluating and mitigating severe risk.",
      "pred": "entailment",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": true,
    "error_info": []
  },
  {
    "problem_id": "40",
    "pred_problem_type": "Risk",
    "reason": [
      "urgent exclusion",
      "not-ruled-out hazard"
    ],
    "goal": "Solve the reasoning problem",
    "premise": "A 49-year-old man with a history of poorly controlled hypertension develops sudden severe tearing chest pain radiating to his back while lifting a heavy box. He is diaphoretic and mildly hypertensive on arrival. ECG shows no acute ischemic changes, and initial troponin is normal. No CT angiography or echocardiography has been performed.",
    "statement": "Aortic dissection must be urgently excluded.",
    "description": "Solve risk reasoning problem. Risk ranking or comparison (highest risk, safer, dangerous), weighing severity against frequency, expected-harm reasoning, and hazards not ruled out by the premise.",
    "label": "entailment",
    "gt_problem_type": "risk",
    "selected_agents": [
      "risk_solver"
    ],
    "excution_dag": "<PLAN_START> -> ques_40, ques_40 -> risk_solver, risk_solver -> <PLAN_END>",
    "solution_history": [
      {
        "reasoning": "Step 1: Extract candidates. The premise mentions sudden severe tearing chest pain radiating to the back, a history of poorly controlled hypertension, and diaphoresis. These are classic symptoms/signs of a life-threatening condition such as an aortic dissection. The lack of CT angiography or echocardiography means that this diagnosis has not been excluded. Step 2: Estimate likelihood. Given the patient's symptoms and risk factors (e.g., poorly controlled hypertension), aortic dissection is a plausible and not-ruled-out condition. Step 3: Assign severity. Aortic dissection is a life-threatening condition associated with catastrophic outcomes (e.g., aortic rupture, organ ischemia) if untreated. Step 4: Compute comparative risk. The risk of overlooking an aortic dissection is very high due to the severity of potential outcomes. Furthermore, no imaging has been performed to exclude it, so it remains a critical consideration. Step 5: Evaluate the statement. The statement aligns with the clinical necessity to prioritize exclusion of life-threatening conditions like aortic dissection in this scenario. Based on the comparative risk, urgent exclusion is essential.",
        "pred": "entailment",
        "fact_verification": "correct",
        "reasoning_verification": "correct",
        "overall_verification": true
      }
    ],
    "solution_final": {
      "reasoning": "Step 1: Extract candidates. The premise mentions sudden severe tearing chest pain radiating to the back, a history of poorly controlled hypertension, and diaphoresis. These are classic symptoms/signs of a life-threatening condition such as an aortic dissection. The lack of CT angiography or echocardiography means that this diagnosis has not been excluded. Step 2: Estimate likelihood. Given the patient's symptoms and risk factors (e.g., poorly controlled hypertension), aortic dissection is a plausible and not-ruled-out condition. Step 3: Assign severity. Aortic dissection is a life-threatening condition associated with catastrophic outcomes (e.g., aortic rupture, organ ischemia) if untreated. Step 4: Compute comparative risk. The risk of overlooking an aortic dissection is very high due to the severity of potential outcomes. Furthermore, no imaging has been performed to exclude it, so it remains a critical consideration. Step 5: Evaluate the statement. The statement aligns with the clinical necessity to prioritize exclusion of life-threatening conditions like aortic dissection in this scenario. Based on the comparative risk, urgent exclusion is essential.",
      "pred": "entailment",
      "fact_verification": "correct",
      "reasoning_verification": "correct",
      "overall_verification": true
    },
    "is_correct": true,
    "error_info": []
  }
]